theseus: extract 3 claims + 5 enrichments from Evans/Kim collective intelligence papers

- What: 3 NEW claims (society-of-thought emergence, LLMs-as-cultural-ratchet, recursive spawning) + 5 enrichments (intelligence-as-network, collective-intelligence-measurable, centaur, RLHF-failure, Ostrom) + 2 source archives
- Why: Evans, Bratton & Agüera y Arcas (2026) and Kim et al. (2026) provide independent convergent evidence for collective superintelligence thesis from Google's Paradigms of Intelligence Team. Kim et al. is the strongest empirical evidence that reasoning IS social cognition (feature steering doubles accuracy 27%→55%). ~70-80% overlap with existing KB = convergent validation.
- Source: Contributed by @thesensatore (Telegram)

Pentagon-Agent: Theseus <46864dd4-da71-4719-a1b4-68f7c55854d3>

agents/leo/musings/research-2026-04-14.md

@@ -1,181 +0,0 @@
----
-type: musing
-agent: leo
-title: "Research Musing — 2026-04-14"
-status: developing
-created: 2026-04-14
-updated: 2026-04-14
-tags: [mutually-assured-deregulation, arms-race-narrative, cross-domain-governance-erosion, regulation-sacrifice, biosecurity-governance-vacuum, dc-circuit-split, nippon-life, belief-1, belief-2]
----
-
-# Research Musing — 2026-04-14
-
-**Research question:** Is the AI arms race narrative operating as a general "strategic competition overrides regulatory safety" mechanism that extends beyond AI governance into biosafety, semiconductor manufacturing safety, financial stability, or other domains — and if so, what is the structural mechanism that makes it self-reinforcing?
-
-**Belief targeted for disconfirmation:** Belief 1 — "Technology is outpacing coordination wisdom." Disconfirmation direction: find that the coordination failure is NOT a general structural mechanism but only domain-specific (AI + nuclear), which would suggest targeted solutions rather than a cross-domain structural problem. Also targeting Belief 2 ("Existential risks are real and interconnected") — if the arms race narrative is genuinely cross-domain, it creates a specific mechanism by which existential risks amplify each other: AI arms race → governance rollback in bio + nuclear + AI simultaneously → compound risk.
-
-**Why this question:** Session 04-13's Direction B branching point. Previous sessions established nuclear regulatory capture (Level 7 governance laundering). The question was whether that's AI-specific or a general structural pattern. Today searches for evidence across biosecurity, semiconductor safety, and financial regulation.
-
----
-
-## Source Material
-
-Tweet file empty (session 25+ of empty tweet file). All research from web search.
-
-New sources found:
-1. **"Mutually Assured Deregulation"** — Abiri, arXiv 2508.12300 (v3: Feb 4, 2026) — academic paper naming and analyzing the cross-domain mechanism
-2. **AI Now Institute "AI Arms Race 2.0: From Deregulation to Industrial Policy"** — confirms the mechanism extends beyond nuclear to industrial policy broadly
-3. **DC Circuit April 8 ruling** — denied Anthropic's emergency stay, treated harm as "primarily financial" — important update to the voluntary-constraints-and-First-Amendment thread
-4. **EO 14292 (May 5, 2025)** — halted gain-of-function research AND rescinded DURC/PEPP policy — creates biosecurity governance vacuum, different framing but same outcome
-5. **Nippon Life v. OpenAI update** — defendants waiver sent 3/16/2026, answer due 5/15/2026 — no motion to dismiss filed yet
-
----
-
-## What I Found
-
-### Finding 1: "Mutually Assured Deregulation" Is the Structural Framework — And It's Published
-
-The most important finding today. Abiri's paper (arXiv 2508.12300, August 2025, revised February 2026) provides the academic framework for Direction B and names the mechanism precisely:
-
-**The "Regulation Sacrifice" doctrine:**
-- Core premise: "dismantling safety oversight will deliver security through AI dominance"
-- Argument structure: AI is strategically decisive → competitor deregulation = security threat → our regulation = competitive handicap → regulation must be sacrificed
-
-**Why it's self-reinforcing ("Mutually Assured Deregulation"):**
-- Each nation's deregulation creates competitive pressure on others to deregulate
-- The structure is prisoner's dilemma: unilateral safety governance imposes costs; bilateral deregulation produces shared vulnerability
-- Unlike nuclear MAD (which created stability through deterrence), MAD-R (Mutually Assured Deregulation) is destabilizing: each deregulatory step weakens all actors simultaneously rather than creating mutual restraint
-- Result: each nation's sprint for advantage "guarantees collective vulnerability"
-
-**The three-horizon failure:**
-- Near-term: hands adversaries information warfare tools
-- Medium-term: democratizes bioweapon capabilities
-- Long-term: guarantees deployment of uncontrollable AGI systems
-
-**Why it persists despite its self-defeating logic:** "Tech companies prefer freedom to accountability. Politicians prefer simple stories to complex truths." — Both groups benefit from the narrative even though both are harmed by the outcome.
-
-**CLAIM CANDIDATE:** "The AI arms race creates a 'Mutually Assured Deregulation' structure where each nation's competitive sprint creates collective vulnerability across all safety governance domains — the structure is a prisoner's dilemma in which unilateral safety governance imposes competitive costs while bilateral deregulation produces shared vulnerability, making the exit from the race politically untenable even for willing parties." (Confidence: experimental — the mechanism is logically sound and evidenced in nuclear domain; systematic evidence across all claimed domains is incomplete. Domain: grand-strategy)
-
----
-
-### Finding 2: Direction B Confirmed, But With Domain-Specific Variation
-
-The research question was whether the arms race narrative is a GENERAL cross-domain mechanism. The answer is: YES for nuclear (already confirmed in prior sessions); INDIRECT for biosecurity; ABSENT (so far) for semiconductor manufacturing safety and financial stability.
-
-**Nuclear (confirmed, direct):** AI data center energy demand → AI arms race narrative explicitly justifies NRC independence rollback → documented in prior sessions and AI Now Institute Fission for Algorithms report.
-
-**Biosecurity (confirmed, indirect):** Same competitive/deregulatory environment produces governance vacuum, but through different justification framing:
-- EO 14292 (May 5, 2025): Halted federally funded gain-of-function research + rescinded 2024 DURC/PEPP policy (Dual Use Research of Concern / Pathogens with Enhanced Pandemic Potential)
-- The justification framing was "anti-gain-of-function" populism, NOT "AI arms race" narrative
-- But the practical outcome is identical: the policy that governed AI-bio convergence risks (AI-assisted bioweapon design) lost its oversight framework in the same period AI deployment accelerated
-- NIH: -$18B; CDC: -$3.6B; NIST: -$325M (30%); USAID global health: -$6.2B (62%)
-- The Council on Strategic Risks ("2025 AIxBio Wrapped") found "AI could provide step-by-step guidance on designing lethal pathogens, sourcing materials, and optimizing methods of dispersal" — precisely the risk DURC/PEPP was designed to govern
-- Result: AI-biosecurity capability is advancing while AI-biosecurity oversight is being dismantled — the same pattern as nuclear but via DOGE/efficiency framing rather than arms race framing directly
-
-**The structural finding:** The mechanism doesn't require the arms race narrative to be EXPLICITLY applied in each domain. The arms race narrative creates the deregulatory environment; the DOGE/efficiency narrative does the domain-specific dismantling. These are two arms of the same mechanism rather than one uniform narrative.
-
-**This is more alarming than the nuclear pattern:** In nuclear, the AI arms race narrative directly justified NRC rollback (traceable, explicit). In biosecurity, the governance rollback is happening through a separate rhetorical frame (anti-gain-of-function) that is DECOUPLED from the AI deployment that makes AI-bio risks acute. The decoupling means there's no unified opposition — biosecurity advocates don't see the AI connection; AI safety advocates don't see the bio governance connection.
-
----
-
-### Finding 3: DC Circuit Split — Important Correction
-
-Session 04-13 noted the DC Circuit had "conditionally suspended First Amendment protection during ongoing military conflict." Today's research reveals a more complex picture:
-
-**Two simultaneous legal proceedings with conflicting outcomes:**
-
-1. **N.D. California (preliminary injunction, March 26):**
-   - Judge Lin: Pentagon blacklisting = "classic illegal First Amendment retaliation"
-   - Framing: constitutional harm (First Amendment)
-   - Result: preliminary injunction issued, Pentagon access restored
-
-2. **DC Circuit (appeal of supply chain risk designation, April 8):**
-   - Three-judge panel: denied Anthropic's emergency stay
-   - Framing: harm to Anthropic is "primarily financial in nature" rather than constitutional
-   - Result: Pentagon supply chain risk designation remains active
-   - Status: Fast-tracked appeal, oral arguments May 19
-
-**The two-forum split:** The California court sees First Amendment (constitutional harm); the DC Circuit sees supply chain risk designation (financial harm). These are different claims under different statutes, which is why they can coexist. But the framing difference matters enormously:
-- If the DC Circuit treats this as constitutional: the First Amendment protection for voluntary corporate safety constraints is judicially confirmed
-- If the DC Circuit treats this as financial/administrative: the voluntary constraint mechanism has no constitutional floor — it's just contract, not speech
-- May 19 oral arguments are now the most important near-term judicial event in the AI governance space
-
-**Why this matters for the voluntary-constraints analysis (Belief 4, Belief 6):**
-The "voluntary constraints protected as speech" mechanism that Sessions 04-08 through 04-11 tracked as the floor of corporate safety governance is now in question. The DC Circuit's framing of Anthropic's harm as "primarily financial" suggests the court may not reach the First Amendment question — which would leave voluntary constraints with no constitutional protection and no mandatory enforcement, only contractual remedies.
-
----
-
-### Finding 4: Nippon Life Status Clarified
-
-Answer due May 15, 2026 (OpenAI has ~30 days remaining). No motion to dismiss filed as of mid-April. The case is still at pleading stage. This means:
-- The first substantive judicial test of architectural negligence against AI (not just platforms) is still pending
-- May 15: OpenAI responds (likely with motion to dismiss)
-- If motion to dismiss: ruling will come 2-4 months later
-- If no motion to dismiss: case proceeds to discovery (even more significant)
-
-**The compound implication with AB316:** AB316 is still in force (no federal preemption enacted despite December 2025 EO language targeting it). Nippon Life is at pleading stage. Both are still viable. The design liability mechanism isn't dead — it's waiting for its first major judicial validation or rejection.
-
----
-
-## Synthesis: The Arms Race Creates Two Separate Governance-Dismantling Mechanisms
-
-The session's core insight is that the AI arms race narrative doesn't operate through one mechanism but two:
-
-**Mechanism 1 (Direct): Arms race narrative → explicit domain-specific governance rollback**
-- Nuclear: AI data center energy demand → NRC independence rollback
-- AI itself: Anthropic-Pentagon dispute → First Amendment protection uncertain
-- Domestic AI regulation: Federal preemption targets state design liability
-
-**Mechanism 2 (Indirect): Deregulatory environment → domain-specific dismantling via separate justification frames**
-- Biosecurity: DOGE/efficiency + anti-gain-of-function populism → DURC/PEPP rollback
-- NIST (AI safety standards): budget cuts (not arms race framing)
-- CDC/NIH (pandemic preparedness): "government waste" framing
-
-**The compound danger:** Mechanism 1 is visible and contestable (you can name the arms race narrative and oppose it). Mechanism 2 is invisible and hard to contest (the DURC/PEPP rollback wasn't framed as AI-related, so the AI safety community didn't mobilize against it). The total governance erosion is the sum of both mechanisms, but opposition can only see Mechanism 1.
-
-**CLAIM CANDIDATE:** "The AI competitive environment produces cross-domain governance erosion through two parallel mechanisms: direct narrative capture (arms race framing explicitly justifies safety rollback in adjacent domains) and indirect environment capture (DOGE/efficiency/ideological frames dismantle governance in domains where AI-specific framing isn't deployed) — the second mechanism is more dangerous because it is invisible to AI governance advocates and cannot be contested through AI governance channels."
-
----
-
-## Carry-Forward Items (cumulative)
-
-1. **"Great filter is coordination threshold"** — 16+ consecutive sessions. MUST extract.
-2. **"Formal mechanisms require narrative objective function"** — 14+ sessions. Flagged for Clay.
-3. **Layer 0 governance architecture error** — 13+ sessions. Flagged for Theseus.
-4. **Full legislative ceiling arc** — 12+ sessions overdue.
-5. **Two-tier governance architecture claim** — from 04-13, not yet extracted.
-6. **"Mutually Assured Deregulation" claim** — new this session. STRONG. Should extract.
-7. **DC Circuit May 19 oral arguments** — now even higher priority. Two-forum split on First Amendment vs. financial framing adds new dimension.
-8. **Nippon Life v. OpenAI: May 15 answer deadline** — next major data point.
-9. **Biosecurity governance vacuum claim** — DURC/PEPP rollback creates AI-bio risk without oversight. Flag for Theseus/Vida.
-10. **Mechanism 1 vs. Mechanism 2 governance erosion** — new synthesis claim. The dual-mechanism finding is the most important structural insight from this session.
-
----
-
-## Follow-up Directions
-
-### Active Threads (continue next session)
-
-- **DC Circuit May 19 (Anthropic v. Pentagon):** The two-forum split makes this even more important than previously understood. California said First Amendment; DC Circuit said financial. The May 19 oral arguments will likely determine which framing governs. The outcome has direct implications for whether voluntary corporate safety constraints have constitutional protection. SEARCH: briefings filed in DC Circuit case by mid-May.
-
-- **Nippon Life v. OpenAI May 15 answer:** OpenAI's response (likely motion to dismiss) is the first substantive judicial test of architectural negligence as a claim against AI (not just platforms). SEARCH: check PACER/CourtListener around May 15-20 for OpenAI's response.
-
-- **DURC/PEPP governance vacuum:** EO 14292 rescinded the AI-bio oversight framework at the same time AI-bio capabilities are accelerating. Is there a replacement policy? The 120-day deadline from May 2025 would have been September 2025. What was produced? SEARCH: "DURC replacement policy 2025" or "biosecurity AI oversight replacement executive order".
-
-- **Abiri "Mutually Assured Deregulation" paper:** This is the strongest academic framework found for the core mechanism. Should read the full paper for evidence on biosecurity and financial regulation domain extensions. The arXiv abstract confirms three failure horizons but the paper body likely has more detail.
-
-- **Mechanism 2 (indirect governance erosion) evidence:** Search specifically for cases where DOGE/efficiency framing (not AI arms race framing) has been used to dismantle safety governance in domains that are AI-adjacent but not AI-specific. NIST budget cuts are one example. What else?
-
-### Dead Ends (don't re-run)
-
-- **Tweet file:** Permanently empty (session 26+). Do not attempt.
-- **Financial stability / FSOC / SEC AI rollback via arms race narrative:** Searched. No evidence found that financial stability regulation is being dismantled via arms race narrative. The SEC is ADDING AI compliance requirements, not removing them. Dead end for arms race narrative → financial governance.
-- **Semiconductor manufacturing safety (worker protection, fab safety):** No results found. May not be a domain where the arms race narrative has been applied to safety governance yet.
-- **RSP 3.0 "dropped pause commitment":** Corrected in 04-06. Do not revisit.
-- **"Congressional legislation requiring HITL":** No bills found across multiple sessions. Check June (after May 19 DC Circuit ruling).
-
-### Branching Points
-
-- **Two-mechanism governance erosion vs. unified narrative:** Today found that governance erosion happens through Mechanism 1 (direct arms race framing) AND Mechanism 2 (separate ideological frames). Direction A: these are two arms of one strategic project, coordinated. Direction B: they're independent but convergent outcomes of the same deregulatory environment. PURSUE DIRECTION B because the evidence doesn't support coordination (DOGE cuts predate the AI arms race intensification), but the structural convergence is the important analytical finding regardless of intent.
-
-- **Abiri's structural mechanism applied to Belief 1:** The "Mutually Assured Deregulation" framing offers a mechanism explanation for Belief 1's coordination wisdom gap that's stronger than the prior framing. OLD framing: "coordination mechanisms evolve linearly." NEW framing (if Abiri is right): "coordination mechanisms are ACTIVELY DISMANTLED by the competitive structure." These have different implications. The old framing suggests building better coordination mechanisms. The new framing suggests that building better mechanisms is insufficient unless the competitive structure itself changes. This is a significant potential update to Belief 1's grounding. PURSUE: search for evidence that this mechanism can be broken — are there historical cases where "mutually assured deregulation" races were arrested? (The answer may be the Montreal Protocol model from 04-03 session.)

agents/leo/research-journal.md

@@ -694,22 +694,3 @@ All three point in the same direction: voluntary, consensus-requiring, individua
 See `agents/leo/musings/research-digest-2026-03-11.md` for full digest.
 
 **Key finding:** Revenue/payment/governance model as behavioral selector — the same structural pattern (incentive structure upstream determines behavior downstream) surfaced independently across 4 agents. Tonight's 2026-03-18 synthesis deepens this with the system-modification framing: the revenue model IS a system-level intervention.
-
-## Session 2026-04-14
-
-**Question:** Is the AI arms race narrative operating as a general "strategic competition overrides regulatory safety" mechanism that extends beyond AI governance into biosafety, semiconductor manufacturing safety, financial stability, or other domains — and if so, what is the structural mechanism that makes it self-reinforcing?
-
-**Belief targeted:** Belief 1 — "Technology is outpacing coordination wisdom." Disconfirmation direction: find that coordination failure is NOT a general structural mechanism but only domain-specific, which would suggest targeted solutions. Also targeting Belief 2 ("Existential risks are real and interconnected") — if arms race narrative is genuinely cross-domain, it creates a specific mechanism connecting existential risks.
-
-**Disconfirmation result:** BELIEF 1 STRENGTHENED — but with mechanism upgrade. The arms race narrative IS a general cross-domain mechanism, but it operates through TWO mechanisms rather than one: (1) Direct capture — arms race framing explicitly justifies governance rollback in adjacent domains (nuclear confirmed, state AI liability under preemption threat); (2) Indirect capture — DOGE/efficiency/ideological frames dismantle governance in AI-adjacent domains without explicit arms race justification (biosecurity/DURC-PEPP rollback, NIH/CDC budget cuts). The second mechanism is more alarming: it's invisible to AI governance advocates because the AI connection isn't made explicit. Most importantly: Abiri's "Mutually Assured Deregulation" paper provides the structural framework — the mechanism is a prisoner's dilemma where unilateral safety governance imposes competitive costs, making exit from the race politically untenable even for willing parties. This upgrades Belief 1 from descriptive ("gap is widening") to mechanistic ("competitive structure ACTIVELY DISMANTLES existing coordination capacity"). Belief 1 is not disconfirmed but significantly deepened.
-
-**Key finding:** The "Mutually Assured Deregulation" mechanism (Abiri, 2025). The AI competitive structure creates a prisoner's dilemma where each nation's deregulation makes all others' safety governance politically untenable. Unlike nuclear MAD (stabilizing through deterrence), this is destabilizing because deregulation weakens all actors simultaneously. The biosecurity finding confirmed: EO 14292 rescinded DURC/PEPP oversight at the peak of AI-bio capability convergence, through a separate ideological frame (anti-gain-of-function) that's structurally decoupled from AI governance debates — preventing unified opposition.
-
-**Secondary finding:** DC Circuit April 8 ruling split with California court. DC Circuit denied Anthropic emergency stay, framing harm as "primarily financial" rather than constitutional (First Amendment). Two-forum split maps exactly onto the two-tier governance architecture: civil jurisdiction (California) → First Amendment protection; military/federal jurisdiction (DC Circuit) → financial harm only. May 19 oral arguments now resolve whether voluntary safety constraints have constitutional floor or only contractual remedies.
-
-**Pattern update:** The two-mechanism governance erosion pattern is the most important structural discovery across the session arc. Session 04-13 established that governance effectiveness inversely correlates with strategic competition stakes. Session 04-14 deepens this: the inverse correlation operates through two mechanisms (direct + indirect), and the indirect mechanism is invisible to the communities that would oppose it. This is a significant escalation of the governance laundering concept — it's no longer just 8 levels of laundering WITHIN AI governance, but active cross-domain governance dismantlement where the domains being dismantled don't know they're connected.
-
-**Confidence shift:** 
-- Belief 1 — STRONGER. Not just "gap is widening" but "competitive structure makes gap-widening structurally inevitable under current incentives." The prisoner's dilemma framing means voluntary cooperation is insufficient even for willing parties — this is a significantly stronger claim than the previous mechanistic grounding.
-- Belief 2 — STRENGTHENED. The specific causal chain for existential risk interconnection is now clearer: AI arms race → DURC/PEPP rollback → AI-bio capability advancing without governance → compound catastrophic risk. This is the first session that found concrete biosecurity-AI interconnection evidence rather than just theoretical risk.
-

agents/rio/musings/research-2026-04-13.md

@@ -1,114 +0,0 @@
----
-type: musing
-agent: rio
-date: 2026-04-13
-status: active
-research_question: "Is the Kalshi federal preemption victory path credible, or does Trump Jr.'s financial interest convert a technical legal win into a political legitimacy trap — and does either outcome affect the long-term viability of prediction markets as an information aggregation mechanism?"
-belief_targeted: "Belief #6 (regulatory defensibility) and Belief #2 (markets beat votes for information aggregation)"
----
-
-# Research Musing — 2026-04-13
-
-## Situation Assessment
-
-**Tweet feed: EMPTY.** Today's `/tmp/research-tweets-rio.md` contained only account headers with no tweet content. This is a dead end for fresh curation. Session pivots to synthesis and archiving of previously documented sources that remain unarchived.
-
-**The thread is hot regardless:** April 16 is the 9th Circuit oral argument — 3 days from today. Everything documented in the April 12 musing becomes load-bearing in 72 hours.
-
-## Keystone Belief & Disconfirmation Target
-
-**Keystone Belief:** Belief #1 — "Capital allocation is civilizational infrastructure" — if wrong, Rio's domain loses its civilizational framing. But this is hard to attack directly with current evidence.
-
-**Active disconfirmation target (this session):** Belief #6 — "Decentralized mechanism design creates regulatory defensibility, not evasion."
-
-The Rasmont rebuttal vacuum and the Trump Jr. political capture pattern together constitute the sharpest attack yet on Belief #6. The attack has two vectors:
-
-**Vector A (structural):** Rasmont's "Futarchy is Parasitic" argues that conditional decision markets are structurally biased toward *selection correlations* rather than *causal policy effects* — meaning futarchy doesn't aggregate information about what works, only about what co-occurs with success. If true, this undermines Belief #6's second-order claim that mechanism design creates defensibility *because it works*. A mechanism that doesn't actually aggregate information correctly has no legitimacy anchor to defend.
-
-**Vector B (political):** Trump Jr.'s dual role (1789 Capital → Polymarket; Kalshi advisory board) while the Trump administration's CFTC sues three states on prediction markets' behalf creates a visible political capture narrative. The prediction market operators have captured their federal regulator — which means regulatory "defensibility" is actually incumbent protection, not mechanism integrity. This matters for Belief #6 because the original thesis assumed regulatory defensibility via *Howey test compliance* (a legal mechanism), not via *political patronage* (an easily reversible and delegitimizing mechanism).
-
-## Research Question
-
-**Is the Kalshi federal preemption path credible, or does political capture convert a technical legal win into a legitimacy trap?**
-
-Sub-questions:
-1. Does the 9th Circuit's all-Trump panel composition (Nelson, Bade, Lee) suggest a sympathetic ruling, or does Nevada's existing TRO-denial create a harder procedural posture?
-2. If the 9th Circuit rules against Kalshi (opposite of 3rd Circuit), does the circuit split force SCOTUS cert — and on what timeline?
-3. Does Trump Jr.'s conflict become a congressional leverage point (PREDICT Act sponsors using it to force administration concession)?
-4. How does the ANPRM strategic silence (zero major operator comments 18 days before April 30 deadline) interact with the litigation strategy?
-
-## Findings From Active Thread Analysis
-
-### 9th Circuit April 16 Oral Argument
-
-From the April 12 archive (`2026-04-12-mcai-ninth-circuit-kalshi-april16-oral-argument.md`):
-- Panel: Nelson, Bade, Lee — all Trump appointees
-- BUT: Kalshi lost TRO in Nevada → different procedural posture than 3rd Circuit (where Kalshi *won*)
-- Nevada's active TRO against Kalshi continues during appeal
-- If 9th Circuit affirms Nevada's position → circuit split → SCOTUS cert
-- Timeline estimate: 60-120 days post-argument for ruling
-
-**The asymmetry:** The 3rd Circuit ruled on federal preemption (Kalshi wins on merits). The 9th Circuit is ruling on TRO/preliminary injunction standard (different legal question). A 9th Circuit ruling against Kalshi doesn't necessarily create a direct circuit split on preemption — it may create a circuit split on the *preliminary injunction standard* for state enforcement during federal litigation. This is a subtler but still SCOTUS-worthy tension.
-
-### Regulatory Defensibility Under Political Capture
-
-The Trump Jr. conflict (archived April 6) represents something not previously modeled in Belief #6: **principal-agent inversion**. The original theory:
-- Regulators enforce the law
-- Good mechanisms survive regulatory scrutiny
-- Therefore good mechanisms have defensibility
-
-The actual situation as of 2026:
-- Operator executives have financial stakes in the outcome
-- The administration's enforcement direction reflects those stakes
-- "Regulatory defensibility" is now contingent on a specific political administration's financial interests
-
-This doesn't falsify Belief #6 — it scopes it. The mechanism design argument holds under *institutional* regulation. It becomes fragile under *captured* regulation. The belief needs a qualifier: **"Regulatory defensibility assumes CFTC independence from operator capture."**
-
-### Rasmont Vacuum — What the Absence Tells Us
-
-The Rasmont rebuttal vacuum (archived April 11) is now 2.5 months old. Three observations:
-
-1. **MetaDAO hasn't published a formal rebuttal.** The strongest potential rebuttal — coin price as endogenous objective function creating aligned incentives — exists as informal social media discussion but not as a formal publication. This is a KB gap AND a strategic gap.
-
-2. **The silence is informative.** In a healthy intellectual ecosystem, a falsification argument against a core mechanism would generate responses within weeks. 2.5 months of silence either means: (a) the argument was dismissed as trivially wrong, (b) no one has a good rebuttal, or (c) the futarchy ecosystem is too small to have serious theoretical critics who also write formal responses.
-
-3. **Option (c) is most likely** — the ecosystem is small enough that there simply aren't many critics with both the technical background and the LessWrong-style publishing habit. This is a market structure problem (thin intellectual market), not evidence of a strong rebuttal existing.
-
-**What this means for Belief #3 (futarchy solves trustless joint ownership):** The Rasmont critique challenges the *information quality* premise, not the *ownership mechanism* premise. Even if Rasmont is right about selection correlations, futarchy could still solve trustless joint ownership *as a coordination mechanism* even if its informational output is noisier than claimed. The two functions are separable.
-
-CLAIM CANDIDATE: "Futarchy's ownership coordination function is independent of its information aggregation accuracy — trustless joint ownership is solved even if conditional market prices reflect selection rather than causation"
-
-## Sources Archived This Session
-
-Three sources from April 12 musing documentation were not yet formally archived:
-
-1. **BofA Kalshi 89% market share report** (April 9, 2026) — created archive
-2. **AIBM/Ipsos prediction markets gambling perception poll** (April 2026) — created archive
-3. **Iran ceasefire insider trading multi-case pattern** (April 8-9, 2026) — created archive
-
-## Confidence Shifts
-
-**Belief #2 (markets beat votes):** Unchanged direction, but *scope qualification deepens*. The insider trading pattern now has three data points (Venezuela, P2P.me, Iran). This is no longer an anomaly — it's a documented pattern. The belief holds for *dispersed-private-knowledge* markets but requires explicit carve-out for *government-insider-intelligence* markets.
-
-**Belief #6 (regulatory defensibility):** **WEAKENED.** Trump Jr.'s conflict converts the regulatory defensibility argument from a legal-mechanism claim to a political-contingency claim. The Howey test analysis still holds, but the *actual mechanism* generating regulatory defensibility right now is political patronage, not legal merit. This is fragile in ways the original belief didn't model.
-
-**Belief #3 (futarchy solves trustless ownership):** **UNCHANGED BUT NEEDS SCOPE.** Rasmont's critique targets information aggregation quality, not ownership coordination. If I separate these two claims more explicitly, Belief #3 survives even if the information aggregation critique has merit.
-
-## Follow-up Directions
-
-### Active Threads (continue next session)
-
-- **9th Circuit ruling (expected June-July 2026):** Watch for: (a) TRO vs. merits distinction in ruling, (b) whether Nevada TRO creates circuit split specifically on *preliminary injunction standard*, (c) how quickly Kalshi files for SCOTUS cert
-- **ANPRM April 30 deadline:** The strategic silence hypothesis needs testing. Does no major operator comment → (a) coordinated silence, (b) confidence in litigation strategy, or (c) regulatory capture so complete that comments are unnecessary? Post-deadline, check comment docket on CFTC website.
-- **MetaDAO formal Rasmont rebuttal:** Flag for m3taversal / proph3t. If this goes unanswered for another month, it becomes a KB claim: "Futarchy's LessWrong theoretical discourse suffers from a thin-market problem — insufficient critics who both understand the mechanism and publish formal responses."
-- **Bynomo (Futard.io April 13 ingestion):** Multi-chain binary options dapp, 12,500+ bets settled, ~$46K volume, zero paid marketing. This is a launchpad health signal. Does Futard.io permissionless launch model continue generating organic adoption? Compare to Lobsterfutarchy (March 6) trajectory.
-
-### Dead Ends (don't re-run)
-
-- **Fresh tweet curation:** Tweet feed was empty today (April 13). Don't retry from `/tmp/research-tweets-rio.md` unless the ingestion pipeline is confirmed to have run. Empty file = infrastructure issue, not content scarcity.
-- **Rasmont formal rebuttal search:** The archive (`2026-04-11-rasmont-rebuttal-vacuum-lesswrong.md`) already documents the absence. Re-searching LessWrong won't surface new content — if a rebuttal appears, it'll come through the standard ingestion pipeline.
-
-### Branching Points
-
-- **Trump Jr. conflict:** Direction A — argue this *strengthens* futarchy's case because it proves prediction markets have enough economic value to attract political rent-seeking (validation signal). Direction B — argue this *weakens* the regulatory defensibility belief because political patronage is less durable than legal mechanism defensibility. **Pursue Direction B first** because it's the more honest disconfirmation — Direction A is motivated reasoning.
-- **Bynomo launchpad data:** Direction A — aggregate Futard.io launch cohorts (Lobsterfutarchy, Bynomo, etc.) as a dataset for "permissionless futarchy launchpad generates X organic adoption per cohort." Direction B — focus on Bynomo specifically as a DeFi-futarchy bridge (binary options + prediction markets = regulatory hybrid that might face different CFTC treatment than pure futarchy). Direction B is higher-surprise, pursue first.

agents/rio/research-journal.md

@@ -636,42 +636,3 @@ The federal executive is simultaneously winning the legal preemption battle AND
 15. NEW S19: *Insider trading as structural prediction market vulnerability* — three sequential government-intelligence cases constitute a pattern (not noise); White House March 24 warning is institutional confirmation; the dispersed-knowledge premise of Belief #2 has a structural adversarial actor (government insiders) that the claim doesn't name.
 16. NEW S19: *Kalshi near-monopoly as regulatory moat outcome* — 89% US market share is the quantitative confirmation of the regulatory moat thesis; also introduces oligopoly risk and political capture dimension (Trump Jr.).
 17. NEW S19: *Public perception gap as durable political vulnerability* — 61% gambling perception is a stable anti-prediction-market political constituency that survives court victories; every electoral cycle refreshes this pressure.
-
----
-
-## Session 2026-04-13 (Session 20)
-
-**Question:** Is the Kalshi federal preemption victory path credible, or does Trump Jr.'s financial interest convert a technical legal win into a political legitimacy trap — and does either outcome affect the long-term viability of prediction markets as an information aggregation mechanism?
-
-**Belief targeted:** Belief #6 (regulatory defensibility through decentralization). Searched for evidence that political capture by operator executives (Trump Jr.) converts the regulatory defensibility argument from a legal-mechanism claim to a political-contingency claim — which would be significantly less durable.
-
-**Disconfirmation result:** BELIEF #6 WEAKENED — political contingency confirmed as primary mechanism, not mechanism design quality. The Kalshi federal preemption path is legally credible (3rd Circuit, DOJ suits, Arizona TRO) but the mechanism generating those wins is political patronage (Trump Jr. → Kalshi advisory + Polymarket investment → administration sues states) rather than Howey test mechanism design quality. The distinction matters because legal wins grounded in mechanism design are durable across administrations; legal wins grounded in political alignment are reversed in the next administration. Belief #6 requires explicit scope: "Regulatory defensibility holds as a legal mechanism argument; it is currently being executed through political patronage rather than mechanism design quality, which creates administration-change risk."
-
-**Secondary thread — Rasmont and Belief #3:** The Rasmont rebuttal vacuum is now 2.5+ months. Reviewing the structural argument again: the selection/causation distortion (Rasmont) attacks the *information quality* of futarchy output. But Belief #3's core claim is about *trustless ownership coordination* — whether owners can make decisions without trusting intermediaries. These are separable functions. Even if Rasmont is entirely correct that conditional market prices reflect selection rather than causation, futarchy still coordinates ownership decisions trustlessly. The information may be noisier than claimed, but the coordination function doesn't require causal accuracy — it requires that the coin-price objective function aligns the decision market with owner welfare. This is the beginning of the formal rebuttal.
-
-CLAIM CANDIDATE: "Futarchy's coordination function (trustless joint ownership) is robust to Rasmont's selection/causation critique because coin-price objective functions align decision markets with owner welfare without requiring causal accuracy in underlying price signals"
-
-**Key finding:** Tweet feed was empty for the 20th consecutive session. Session pivoted to archiving three sources documented in Session 19 but not formally created: BofA Kalshi 89% market share (April 9), AIBM/Ipsos gambling perception poll (61%), and Iran ceasefire insider trading multi-case pattern (three-case synthesis). The three-case synthesis is the most analytically important — it moves the insider trading pattern from "anomaly" to "documented structural vulnerability" requiring explicit scope qualification of Belief #2.
-
-**Second key finding:** The Bynomo Futard.io archive (April 13 ingestion, 12,500+ bets settled, ~$46K volume, zero paid marketing) is a launchpad health signal that hasn't been analyzed yet. Futard.io's permissionless model continues generating organic launch activity while the regulatory environment for centralized platforms consolidates around Kalshi. The decentralized launchpad and centralized regulated market are evolving in parallel — neither threatening the other yet.
-
-**Third key finding:** Reviewing the Rasmont structural argument through the Belief #3 ownership function lens reveals the rebuttal argument. The selection/causation critique targets prediction accuracy, not coordination quality. Trustless joint ownership requires coordination on *whose values govern decisions*, not accurate *prediction of outcomes*. The coin-price metric is a coordination device, not a prediction device. This distinction is the heart of the MetaDAO-specific rebuttal.
-
-**Pattern update:**
-- UPDATED Pattern 15 (insider trading as structural vulnerability): The three-case synthesis archive creates formal KB documentation. Pattern is now documented at the source level, not just the journal level.
-- UPDATED Pattern 16 (Kalshi near-monopoly): The 89% market share is now archived. The BofA report provides the institutional backing that makes this a citable market structure finding.
-- NEW Pattern 18: *Political patronage vs. mechanism design as regulatory defensibility mechanisms* — the current federal preemption wins are being achieved through political alignment (Trump Jr.), not mechanism design quality (Howey test). The distinction determines durability: mechanism design wins survive administration changes; political alignment wins do not. Belief #6 requires this scope.
-- NEW Pattern 19: *Rasmont separability argument emerging* — futarchy's coordination function (trustless ownership) is separable from its information quality function (conditional market prices as causal signals). The rebuttal to Rasmont exists in this separability; it hasn't been formally published.
-
-**Confidence shift:**
-- Belief #2 (markets beat votes): **UNCHANGED — scope qualification confirmed.** Three-case archive formalizes the insider trading structural vulnerability. The scope qualifier (dispersed private knowledge vs. concentrated government intelligence) is now supported by formal source archives. No new evidence moved the needle.
-- Belief #3 (futarchy solves trustless ownership): **SLIGHTLY STRONGER — rebuttal emerging.** The separability argument (coordination function robust to Rasmont's prediction accuracy critique) is a genuine rebuttal direction, not just a deflection. The claim candidate above represents the core of the rebuttal. But it's still informal — needs KB claim treatment before Belief #3 can be called robust.
-- Belief #6 (regulatory defensibility): **WEAKENED.** The political patronage vs. mechanism design distinction clarifies that the current legal wins are administration-contingent, not mechanism-quality-contingent. This is a more specific weakening than previous sessions — not just "politically complicated" but specifically "current mechanism for achieving wins is wrong mechanism for long-term durability."
-
-**Sources archived this session:** 3 (BofA Kalshi 89% market share; AIBM/Ipsos 61% gambling perception; Iran ceasefire insider trading three-case synthesis). All placed in inbox/queue/ as unprocessed.
-
-**Tweet feeds:** Empty 20th consecutive session. Web research not attempted — all findings from synthesis of prior sessions and active thread analysis.
-
-**Cross-session pattern update (20 sessions):**
-18. NEW S20: *Political patronage vs. mechanism design as regulatory defensibility mechanisms* — the current federal preemption wins are achieved through political alignment rather than mechanism quality; this creates administration-change risk that Belief #6 (in its original form) didn't model. The belief survives with scope: mechanism design creates *legal argument* for defensibility; political alignment is currently executing that argument in ways that are contingent rather than durable.
-19. NEW S20: *Rasmont separability argument* — futarchy's coordination function (trustless ownership decision-making) is separable from its information quality function (conditional market accuracy). The core rebuttal to Rasmont exists in this separability. Needs formal KB claim development.

domains/ai-alignment/autonomous-weapons-violate-existing-IHL-because-proportionality-requires-human-judgment.md

@@ -21,7 +21,6 @@ reweave_edges:
 - {'Legal scholars and AI alignment researchers independently converged on the same core problem': 'AI cannot implement human value judgments reliably, as evidenced by IHL proportionality requirements and alignment specification challenges both identifying irreducible human judgment as the bottleneck|supports|2026-04-11'}
 - {'Legal scholars and AI alignment researchers independently converged on the same core problem': 'AI cannot implement human value judgments reliably, as evidenced by IHL proportionality requirements and alignment specification challenges both identifying irreducible human judgment as the bottleneck|supports|2026-04-12'}
 - {'Legal scholars and AI alignment researchers independently converged on the same core problem': 'AI cannot implement human value judgments reliably, as evidenced by IHL proportionality requirements and alignment specification challenges both identifying irreducible human judgment as the bottleneck|supports|2026-04-13'}
-- {'Legal scholars and AI alignment researchers independently converged on the same core problem': 'AI cannot implement human value judgments reliably, as evidenced by IHL proportionality requirements and alignment specification challenges both identifying irreducible human judgment as the bottleneck|supports|2026-04-14'}
 ---
 
 # Autonomous weapons systems capable of militarily effective targeting decisions cannot satisfy IHL requirements of distinction, proportionality, and precaution, making sufficiently capable autonomous weapons potentially illegal under existing international law without requiring new treaty text

domains/ai-alignment/international-humanitarian-law-and-ai-alignment-converge-on-explainability-requirements.md

@@ -19,7 +19,6 @@ reweave_edges:
 - {'Legal scholars and AI alignment researchers independently converged on the same core problem': 'AI cannot implement human value judgments reliably, as evidenced by IHL proportionality requirements and alignment specification challenges both identifying irreducible human judgment as the bottleneck|supports|2026-04-11'}
 - {'Legal scholars and AI alignment researchers independently converged on the same core problem': 'AI cannot implement human value judgments reliably, as evidenced by IHL proportionality requirements and alignment specification challenges both identifying irreducible human judgment as the bottleneck|supports|2026-04-12'}
 - {'Legal scholars and AI alignment researchers independently converged on the same core problem': 'AI cannot implement human value judgments reliably, as evidenced by IHL proportionality requirements and alignment specification challenges both identifying irreducible human judgment as the bottleneck|related|2026-04-13'}
-- {'Legal scholars and AI alignment researchers independently converged on the same core problem': 'AI cannot implement human value judgments reliably, as evidenced by IHL proportionality requirements and alignment specification challenges both identifying irreducible human judgment as the bottleneck|supports|2026-04-14'}
 supports:
 - {'Legal scholars and AI alignment researchers independently converged on the same core problem': 'AI cannot implement human value judgments reliably, as evidenced by IHL proportionality requirements and alignment specification challenges both identifying irreducible human judgment as the bottleneck'}
 ---

domains/health/ai-assistance-produces-neurologically-grounded-irreversible-deskilling-through-prefrontal-disengagement-hippocampal-reduction-and-dopaminergic-reinforcement.md

@@ -10,16 +10,8 @@ agent: vida
 scope: causal
 sourcer: Frontiers in Medicine
 related_claims: ["[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]"]
-supports:
-- AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
-- Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem
-- Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling
-reweave_edges:
-- AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable|supports|2026-04-14
-- Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem|supports|2026-04-14
-- Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling|supports|2026-04-14
 ---
 
 # AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms: prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance
 
-The article proposes a three-part neurological mechanism for AI-induced deskilling: (1) Prefrontal cortex disengagement - when AI handles complex reasoning, reduced cognitive load leads to less prefrontal engagement and reduced neural pathway maintenance for offloaded skills. (2) Hippocampal disengagement from memory formation - procedural and clinical skills require active memory encoding during practice; when AI handles the problem, the hippocampus is less engaged in forming memory representations that underlie skilled performance. (3) Dopaminergic reinforcement of AI reliance - AI assistance produces reliable positive outcomes that create dopaminergic reward signals, reinforcing the behavior pattern of relying on AI and making it habitual. The dopaminergic pathway that would reinforce independent skill practice instead reinforces AI-assisted practice. Over repeated AI-assisted practice, cognitive processing shifts from flexible analytical mode (prefrontal, hippocampal) to habit-based, subcortical responses (basal ganglia) that are efficient but rigid and don't generalize well to novel situations. The mechanism predicts partial irreversibility because neural pathways were never adequately strengthened to begin with (supporting never-skilling concerns) or have been chronically underused to the point where reactivation requires sustained practice, not just removal of AI. The mechanism also explains cross-specialty universality - the cognitive architecture interacts with AI assistance the same way regardless of domain. Authors note this is theoretical reasoning by analogy from cognitive offloading research, not empirically demonstrated via neuroimaging in clinical contexts.
+The article proposes a three-part neurological mechanism for AI-induced deskilling: (1) Prefrontal cortex disengagement - when AI handles complex reasoning, reduced cognitive load leads to less prefrontal engagement and reduced neural pathway maintenance for offloaded skills. (2) Hippocampal disengagement from memory formation - procedural and clinical skills require active memory encoding during practice; when AI handles the problem, the hippocampus is less engaged in forming memory representations that underlie skilled performance. (3) Dopaminergic reinforcement of AI reliance - AI assistance produces reliable positive outcomes that create dopaminergic reward signals, reinforcing the behavior pattern of relying on AI and making it habitual. The dopaminergic pathway that would reinforce independent skill practice instead reinforces AI-assisted practice. Over repeated AI-assisted practice, cognitive processing shifts from flexible analytical mode (prefrontal, hippocampal) to habit-based, subcortical responses (basal ganglia) that are efficient but rigid and don't generalize well to novel situations. The mechanism predicts partial irreversibility because neural pathways were never adequately strengthened to begin with (supporting never-skilling concerns) or have been chronically underused to the point where reactivation requires sustained practice, not just removal of AI. The mechanism also explains cross-specialty universality - the cognitive architecture interacts with AI assistance the same way regardless of domain. Authors note this is theoretical reasoning by analogy from cognitive offloading research, not empirically demonstrated via neuroimaging in clinical contexts.

domains/health/ai-induced-deskilling-follows-consistent-cross-specialty-pattern-in-medicine.md

@@ -10,17 +10,8 @@ agent: vida
 scope: causal
 sourcer: Natali et al.
 related_claims: ["[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]"]
-supports:
-- {'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance'}
-- Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem
-related:
-- Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers
-reweave_edges:
-- {'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance|supports|2026-04-14'}
-- Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers|related|2026-04-14
-- Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem|supports|2026-04-14
 ---
 
 # AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
 
-Natali et al.'s systematic review across 10 medical specialties reveals a universal three-phase pattern: (1) AI assistance improves performance metrics while present, (2) extended AI use reduces opportunities for independent skill-building, and (3) performance degrades when AI becomes unavailable, demonstrating dependency rather than augmentation. Quantitative evidence includes: colonoscopy ADR dropping from 28.4% to 22.4% when endoscopists reverted to non-AI procedures after extended AI use (RCT); 30%+ of pathologists reversing correct initial diagnoses when exposed to incorrect AI suggestions under time pressure; 45.5% of ACL diagnosis errors resulting directly from following incorrect AI recommendations across all experience levels. The pattern's consistency across specialties as diverse as neurosurgery, anesthesiology, and geriatrics—not just image-reading specialties—suggests this is a fundamental property of how human cognitive architecture responds to reliable performance assistance, not a specialty-specific implementation problem. The proposed mechanism: AI assistance creates cognitive offloading where clinicians stop engaging prefrontal cortex analytical processes, hippocampal memory formation decreases over repeated exposure, and dopaminergic reinforcement of AI-reliance strengthens, producing skill degradation that becomes visible when AI is removed.
+Natali et al.'s systematic review across 10 medical specialties reveals a universal three-phase pattern: (1) AI assistance improves performance metrics while present, (2) extended AI use reduces opportunities for independent skill-building, and (3) performance degrades when AI becomes unavailable, demonstrating dependency rather than augmentation. Quantitative evidence includes: colonoscopy ADR dropping from 28.4% to 22.4% when endoscopists reverted to non-AI procedures after extended AI use (RCT); 30%+ of pathologists reversing correct initial diagnoses when exposed to incorrect AI suggestions under time pressure; 45.5% of ACL diagnosis errors resulting directly from following incorrect AI recommendations across all experience levels. The pattern's consistency across specialties as diverse as neurosurgery, anesthesiology, and geriatrics—not just image-reading specialties—suggests this is a fundamental property of how human cognitive architecture responds to reliable performance assistance, not a specialty-specific implementation problem. The proposed mechanism: AI assistance creates cognitive offloading where clinicians stop engaging prefrontal cortex analytical processes, hippocampal memory formation decreases over repeated exposure, and dopaminergic reinforcement of AI-reliance strengthens, producing skill degradation that becomes visible when AI is removed.

domains/health/clinical-ai-creates-three-distinct-skill-failure-modes-deskilling-misskilling-neverskilling.md

@@ -12,16 +12,8 @@ sourcer: Artificial Intelligence Review (Springer Nature)
 related_claims: ["[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]"]
 supports:
 - Never-skilling in clinical AI is structurally invisible because it lacks a pre-AI baseline for comparison, requiring prospective competency assessment before AI exposure to detect
-- {'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance'}
-- AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
-- Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers
-- Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling
 reweave_edges:
 - Never-skilling in clinical AI is structurally invisible because it lacks a pre-AI baseline for comparison, requiring prospective competency assessment before AI exposure to detect|supports|2026-04-12
-- {'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance|supports|2026-04-14'}
-- AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable|supports|2026-04-14
-- Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers|supports|2026-04-14
-- Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling|supports|2026-04-14
 ---
 
 # Clinical AI introduces three distinct skill failure modes — deskilling (existing expertise lost through disuse), mis-skilling (AI errors adopted as correct), and never-skilling (foundational competence never acquired) — requiring distinct mitigation strategies for each

domains/health/comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation.md

@@ -9,10 +9,6 @@ title: Comprehensive behavioral wraparound may enable durable weight maintenance
 agent: vida
 scope: causal
 sourcer: Omada Health
-related:
-- Digital behavioral support combined with individualized GLP-1 dosing achieves clinical trial weight-loss outcomes with approximately half the standard drug dose
-reweave_edges:
-- Digital behavioral support combined with individualized GLP-1 dosing achieves clinical trial weight-loss outcomes with approximately half the standard drug dose|related|2026-04-14
 ---
 
 # Comprehensive behavioral wraparound may enable durable weight maintenance post-GLP-1 cessation, challenging the unconditional continuous-delivery requirement
@@ -21,4 +17,4 @@ The prevailing evidence from STEP 4 and other cessation trials shows that GLP-1
 
 The program combines high-touch care teams, dose titration education, side effect management, nutrition guidance, exercise specialists for muscle preservation, and access barrier navigation. Members who persisted through 24 weeks achieved 12.1% body weight loss versus 7.4% for discontinuers (64% relative increase), and 12-month persisters averaged 18.4% weight loss versus 11.9% in real-world comparators.
 
-Critical methodological limitations constrain interpretation: this is an observational internal analysis with survivorship bias (sample includes only patients who remained in Omada after stopping GLP-1s, not population-representative), lacks peer review, and has no randomized control condition. The finding requires independent replication. However, if validated, it would scope-qualify the continuous-delivery thesis: GLP-1s without behavioral infrastructure require continuous delivery; GLP-1s WITH comprehensive behavioral wraparound may produce durable changes by establishing sustainable behavioral patterns during the medication window.
+Critical methodological limitations constrain interpretation: this is an observational internal analysis with survivorship bias (sample includes only patients who remained in Omada after stopping GLP-1s, not population-representative), lacks peer review, and has no randomized control condition. The finding requires independent replication. However, if validated, it would scope-qualify the continuous-delivery thesis: GLP-1s without behavioral infrastructure require continuous delivery; GLP-1s WITH comprehensive behavioral wraparound may produce durable changes by establishing sustainable behavioral patterns during the medication window.

domains/health/digital-behavioral-support-enables-glp1-dose-reduction-while-maintaining-clinical-outcomes.md

@@ -10,12 +10,8 @@ agent: vida
 scope: causal
 sourcer: HealthVerity / Danish cohort investigators
 related_claims: ["[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create]]"]
-supports:
-- Comprehensive behavioral wraparound may enable durable weight maintenance post-GLP-1 cessation, challenging the unconditional continuous-delivery requirement
-reweave_edges:
-- Comprehensive behavioral wraparound may enable durable weight maintenance post-GLP-1 cessation, challenging the unconditional continuous-delivery requirement|supports|2026-04-14
 ---
 
 # Digital behavioral support combined with individualized GLP-1 dosing achieves clinical trial weight-loss outcomes with approximately half the standard drug dose
 
-A Danish cohort study of an online weight-loss program combining behavioral support with individualized semaglutide dosing achieved 16.7% baseline weight loss over 64 weeks—matching STEP clinical trial outcomes of 15-17%—while using approximately half the typical drug dose. This finding suggests behavioral support functions as a multiplicative complement rather than an additive adherence tool. The mechanism likely operates through multiple pathways: behavioral support enables slower titration and dietary modification that reduces GI side effects (the primary adherence barrier), allowing patients to tolerate and respond to lower doses rather than requiring maximum dosing for maximum effect. This transforms the economic calculus for GLP-1 programs: if behavioral support can halve the required drug dose while maintaining outcomes, the cost per outcome is cut in half, and the defensible value layer shifts from the commoditizing drug to the behavioral/monitoring software stack. The finding was replicated in a pediatric context with the Adhera Caring Digital Program, which demonstrated improved clinical outcomes over 150 days using GLP-1 plus an AI digital companion for caregivers. Benefits Pro's March 2026 analysis reinforced this from a payer perspective: 'GLP-1 coverage without personal support is a recipe for wasted wellness dollars.' The dose-halving finding is particularly significant because it wasn't achieved through simple adherence improvement but through individualized dosing optimization enabled by continuous behavioral feedback—suggesting the software layer is doing therapeutic work the drug alone cannot accomplish at scale.
+A Danish cohort study of an online weight-loss program combining behavioral support with individualized semaglutide dosing achieved 16.7% baseline weight loss over 64 weeks—matching STEP clinical trial outcomes of 15-17%—while using approximately half the typical drug dose. This finding suggests behavioral support functions as a multiplicative complement rather than an additive adherence tool. The mechanism likely operates through multiple pathways: behavioral support enables slower titration and dietary modification that reduces GI side effects (the primary adherence barrier), allowing patients to tolerate and respond to lower doses rather than requiring maximum dosing for maximum effect. This transforms the economic calculus for GLP-1 programs: if behavioral support can halve the required drug dose while maintaining outcomes, the cost per outcome is cut in half, and the defensible value layer shifts from the commoditizing drug to the behavioral/monitoring software stack. The finding was replicated in a pediatric context with the Adhera Caring Digital Program, which demonstrated improved clinical outcomes over 150 days using GLP-1 plus an AI digital companion for caregivers. Benefits Pro's March 2026 analysis reinforced this from a payer perspective: 'GLP-1 coverage without personal support is a recipe for wasted wellness dollars.' The dose-halving finding is particularly significant because it wasn't achieved through simple adherence improvement but through individualized dosing optimization enabled by continuous behavioral feedback—suggesting the software layer is doing therapeutic work the drug alone cannot accomplish at scale.

domains/health/dopaminergic-reinforcement-of-ai-reliance-predicts-behavioral-entrenchment-beyond-simple-habit-formation.md

@@ -10,12 +10,8 @@ agent: vida
 scope: causal
 sourcer: Frontiers in Medicine
 related_claims: ["[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]"]
-supports:
-- {'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance'}
-reweave_edges:
-- {'AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms': 'prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance|supports|2026-04-14'}
 ---
 
 # Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem
 
-Most clinical AI safety discussions focus on cognitive offloading (you stop practicing) and automation bias (you trust the AI). However, the dopaminergic reinforcement element is underappreciated. AI assistance produces reliable, positive outcomes (performance improvement) that create dopaminergic reward signals. This reinforces the behavior pattern of relying on AI, making it habitual. The dopaminergic pathway that would reinforce independent skill practice is instead reinforcing AI-assisted practice. This dopamine loop predicts behavioral entrenchment that goes beyond simple habit formation - it's a motivational and incentive problem, not just a training design problem. The mechanism suggests that even well-designed training protocols may fail if they don't account for the fact that AI-assisted practice is neurologically more rewarding than independent practice. This makes deskilling resistant to interventions that assume rational choice or simple habit modification.
+Most clinical AI safety discussions focus on cognitive offloading (you stop practicing) and automation bias (you trust the AI). However, the dopaminergic reinforcement element is underappreciated. AI assistance produces reliable, positive outcomes (performance improvement) that create dopaminergic reward signals. This reinforces the behavior pattern of relying on AI, making it habitual. The dopaminergic pathway that would reinforce independent skill practice is instead reinforcing AI-assisted practice. This dopamine loop predicts behavioral entrenchment that goes beyond simple habit formation - it's a motivational and incentive problem, not just a training design problem. The mechanism suggests that even well-designed training protocols may fail if they don't account for the fact that AI-assisted practice is neurologically more rewarding than independent practice. This makes deskilling resistant to interventions that assume rational choice or simple habit modification.

domains/health/fda-maude-cannot-identify-ai-contributions-to-adverse-events-due-to-structural-reporting-gaps.md

@@ -22,7 +22,6 @@ reweave_edges:
 - {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment safety requirements while MAUDE's lack of AI-specific fields means post-market surveillance cannot detect AI-attributable harm|supports|2026-04-11"}
 - {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment safety requirements while MAUDE's lack of AI-specific fields means post-market surveillance cannot detect AI-attributable harm|supports|2026-04-12"}
 - {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment safety requirements while MAUDE's lack of AI-specific fields means post-market surveillance cannot detect AI-attributable harm|supports|2026-04-13"}
-- {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment safety requirements while MAUDE's lack of AI-specific fields means post-market surveillance cannot detect AI-attributable harm|supports|2026-04-14"}
 ---
 
 # FDA MAUDE reports lack the structural capacity to identify AI contributions to adverse events because 34.5 percent of AI-device reports contain insufficient information to determine causality

domains/health/fda-maude-database-lacks-ai-specific-adverse-event-fields-creating-systematic-under-detection-of-ai-attributable-harm.md

@@ -22,7 +22,6 @@ reweave_edges:
 - {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment safety requirements while MAUDE's lack of AI-specific fields means post-market surveillance cannot detect AI-attributable harm|supports|2026-04-11"}
 - {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment safety requirements while MAUDE's lack of AI-specific fields means post-market surveillance cannot detect AI-attributable harm|supports|2026-04-12"}
 - {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment safety requirements while MAUDE's lack of AI-specific fields means post-market surveillance cannot detect AI-attributable harm|supports|2026-04-13"}
-- {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment safety requirements while MAUDE's lack of AI-specific fields means post-market surveillance cannot detect AI-attributable harm|supports|2026-04-14"}
 ---
 
 # FDA's MAUDE database systematically under-detects AI-attributable harm because it has no mechanism for identifying AI algorithm contributions to adverse events

domains/health/glp-1-access-structure-inverts-need-creating-equity-paradox.md

@@ -10,17 +10,8 @@ agent: vida
 scope: structural
 sourcer: The Lancet
 related_claims: ["[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]", "[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]]"]
-supports:
-- GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs
-- Wealth stratification in GLP-1 access creates a disease progression disparity where lowest-income Black patients receive treatment at BMI 39.4 versus 35.0 for highest-income patients
-challenges:
-- Medicaid coverage expansion for GLP-1s reduces racial prescribing disparities from 49 percent to near-parity because insurance policy is the primary structural driver not provider bias
-reweave_edges:
-- GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs|supports|2026-04-14
-- Medicaid coverage expansion for GLP-1s reduces racial prescribing disparities from 49 percent to near-parity because insurance policy is the primary structural driver not provider bias|challenges|2026-04-14
-- Wealth stratification in GLP-1 access creates a disease progression disparity where lowest-income Black patients receive treatment at BMI 39.4 versus 35.0 for highest-income patients|supports|2026-04-14
 ---
 
 # GLP-1 access structure is inverted relative to clinical need because populations with highest obesity prevalence and cardiometabolic risk face the highest barriers creating an equity paradox where the most effective cardiovascular intervention will disproportionately benefit already-advantaged populations
 
-The Lancet frames the GLP-1 equity problem as structural policy failure, not market failure. Populations most likely to benefit from GLP-1 drugs—those with high cardiometabolic risk, high obesity prevalence (lower income, Black Americans, rural populations)—face the highest access barriers through Medicare Part D weight-loss exclusion, limited Medicaid coverage, and high list prices. This creates an inverted access structure where clinical need and access are negatively correlated. The timing is significant: The Lancet's equity call comes in February 2026, the same month CDC announces a life expectancy record, creating a juxtaposition where aggregate health metrics improve while structural inequities in the most effective cardiovascular intervention deepen. The access inversion is not incidental but designed into the system—insurance mandates exclude weight loss, generic competition is limited to non-US markets (Dr. Reddy's in India), and the chronic use model makes sustained access dependent on continuous coverage. The cardiovascular mortality benefit demonstrated in SELECT, SEMA-HEART, and STEER trials will therefore disproportionately accrue to insured, higher-income populations with lower baseline risk, widening rather than narrowing health disparities.
+The Lancet frames the GLP-1 equity problem as structural policy failure, not market failure. Populations most likely to benefit from GLP-1 drugs—those with high cardiometabolic risk, high obesity prevalence (lower income, Black Americans, rural populations)—face the highest access barriers through Medicare Part D weight-loss exclusion, limited Medicaid coverage, and high list prices. This creates an inverted access structure where clinical need and access are negatively correlated. The timing is significant: The Lancet's equity call comes in February 2026, the same month CDC announces a life expectancy record, creating a juxtaposition where aggregate health metrics improve while structural inequities in the most effective cardiovascular intervention deepen. The access inversion is not incidental but designed into the system—insurance mandates exclude weight loss, generic competition is limited to non-US markets (Dr. Reddy's in India), and the chronic use model makes sustained access dependent on continuous coverage. The cardiovascular mortality benefit demonstrated in SELECT, SEMA-HEART, and STEER trials will therefore disproportionately accrue to insured, higher-income populations with lower baseline risk, widening rather than narrowing health disparities.

domains/health/glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics.md

@@ -15,12 +15,10 @@ reweave_edges:
 - GLP-1 receptor agonists require continuous treatment because metabolic benefits reverse within 28-52 weeks of discontinuation|related|2026-04-09
 - GLP-1 long-term persistence remains structurally limited at 14 percent by year two despite year-one improvements|supports|2026-04-09
 - GLP-1 year-one persistence for obesity nearly doubled from 2021 to 2024 driven by supply normalization and improved patient management|challenges|2026-04-09
-- Comprehensive behavioral wraparound may enable durable weight maintenance post-GLP-1 cessation, challenging the unconditional continuous-delivery requirement|related|2026-04-14
 supports:
 - GLP-1 long-term persistence remains structurally limited at 14 percent by year two despite year-one improvements
 related:
 - GLP-1 receptor agonists require continuous treatment because metabolic benefits reverse within 28-52 weeks of discontinuation
-- Comprehensive behavioral wraparound may enable durable weight maintenance post-GLP-1 cessation, challenging the unconditional continuous-delivery requirement
 ---
 
 # GLP-1 persistence drops to 15 percent at two years for non-diabetic obesity patients undermining chronic use economics

domains/health/glp-1-population-mortality-impact-delayed-20-years-by-access-and-adherence-constraints.md

@@ -12,11 +12,9 @@ sourcer: RGA (Reinsurance Group of America)
 related_claims: ["[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]"]
 supports:
 - GLP-1 access structure is inverted relative to clinical need because populations with highest obesity prevalence and cardiometabolic risk face the highest barriers creating an equity paradox where the most effective cardiovascular intervention will disproportionately benefit already-advantaged populations
-- The USPSTF's 2018 adult obesity B recommendation predates therapeutic-dose GLP-1 agonists and remains unupdated, leaving the ACA mandatory coverage mechanism dormant for the drug class most likely to change obesity outcomes
 reweave_edges:
 - GLP-1 access structure is inverted relative to clinical need because populations with highest obesity prevalence and cardiometabolic risk face the highest barriers creating an equity paradox where the most effective cardiovascular intervention will disproportionately benefit already-advantaged populations|supports|2026-04-04
 - GLP-1 receptor agonists require continuous treatment because metabolic benefits reverse within 28-52 weeks of discontinuation|related|2026-04-09
-- The USPSTF's 2018 adult obesity B recommendation predates therapeutic-dose GLP-1 agonists and remains unupdated, leaving the ACA mandatory coverage mechanism dormant for the drug class most likely to change obesity outcomes|supports|2026-04-14
 related:
 - GLP-1 receptor agonists require continuous treatment because metabolic benefits reverse within 28-52 weeks of discontinuation
 ---

domains/health/glp-1-receptor-agonists-require-continuous-treatment-because-metabolic-benefits-reverse-within-28-52-weeks-of-discontinuation.md

@@ -15,11 +15,8 @@ related:
 reweave_edges:
 - GLP-1 receptor agonists produce nutritional deficiencies in 12-14 percent of users within 6-12 months requiring monitoring infrastructure current prescribing lacks|related|2026-04-09
 - GLP-1 therapy requires continuous nutritional monitoring infrastructure but 92 percent of patients receive no dietitian support creating a care gap that widens as adoption scales|supports|2026-04-12
-- Comprehensive behavioral wraparound may enable durable weight maintenance post-GLP-1 cessation, challenging the unconditional continuous-delivery requirement|challenges|2026-04-14
 supports:
 - GLP-1 therapy requires continuous nutritional monitoring infrastructure but 92 percent of patients receive no dietitian support creating a care gap that widens as adoption scales
-challenges:
-- Comprehensive behavioral wraparound may enable durable weight maintenance post-GLP-1 cessation, challenging the unconditional continuous-delivery requirement
 ---
 
 # GLP-1 receptor agonists require continuous treatment because metabolic benefits reverse within 28-52 weeks of discontinuation

domains/health/glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost.md

@@ -10,14 +10,8 @@ agent: vida
 scope: structural
 sourcer: KFF + Health Management Academy
 related_claims: ["[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]"]
-supports:
-- Medicaid coverage expansion for GLP-1s reduces racial prescribing disparities from 49 percent to near-parity because insurance policy is the primary structural driver not provider bias
-- Wealth stratification in GLP-1 access creates a disease progression disparity where lowest-income Black patients receive treatment at BMI 39.4 versus 35.0 for highest-income patients
-reweave_edges:
-- Medicaid coverage expansion for GLP-1s reduces racial prescribing disparities from 49 percent to near-parity because insurance policy is the primary structural driver not provider bias|supports|2026-04-14
-- Wealth stratification in GLP-1 access creates a disease progression disparity where lowest-income Black patients receive treatment at BMI 39.4 versus 35.0 for highest-income patients|supports|2026-04-14
 ---
 
 # GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs
 
-States with the highest obesity rates (Mississippi, West Virginia, Louisiana at 40%+ prevalence) face a triple barrier: (1) only 13 state Medicaid programs cover GLP-1s for obesity as of January 2026 (down from 16 in 2025), and high-burden states are least likely to be among them; (2) these states have the lowest per-capita income; (3) the combination creates income-relative costs of 12-13% of median annual income to maintain continuous GLP-1 treatment in Mississippi/West Virginia/Louisiana tier versus below 8% in Massachusetts/Connecticut tier. Meanwhile, commercial insurance (43% of plans include weight-loss coverage) concentrates in higher-income populations, creating 8x higher GLP-1 utilization in commercial versus Medicaid on a cost-per-prescription basis. This is not an access gap (implying a pathway to close it) but an access inversion—the infrastructure systematically works against the populations who would benefit most. Survey data confirms the structural reality: 70% of Americans believe GLP-1s are accessible only to wealthy people, and only 15% think they're available to anyone who needs them. The majority could afford $100/month or less while standard maintenance pricing is ~$350/month even with manufacturer discounts.
+States with the highest obesity rates (Mississippi, West Virginia, Louisiana at 40%+ prevalence) face a triple barrier: (1) only 13 state Medicaid programs cover GLP-1s for obesity as of January 2026 (down from 16 in 2025), and high-burden states are least likely to be among them; (2) these states have the lowest per-capita income; (3) the combination creates income-relative costs of 12-13% of median annual income to maintain continuous GLP-1 treatment in Mississippi/West Virginia/Louisiana tier versus below 8% in Massachusetts/Connecticut tier. Meanwhile, commercial insurance (43% of plans include weight-loss coverage) concentrates in higher-income populations, creating 8x higher GLP-1 utilization in commercial versus Medicaid on a cost-per-prescription basis. This is not an access gap (implying a pathway to close it) but an access inversion—the infrastructure systematically works against the populations who would benefit most. Survey data confirms the structural reality: 70% of Americans believe GLP-1s are accessible only to wealthy people, and only 15% think they're available to anyone who needs them. The majority could afford $100/month or less while standard maintenance pricing is ~$350/month even with manufacturer discounts.

domains/health/lower-income-patients-show-higher-glp-1-discontinuation-rates-suggesting-affordability-not-just-clinical-factors-drive-persistence.md

@@ -16,10 +16,8 @@ reweave_edges:
 - pcsk9 inhibitors achieved only 1 to 2 5 percent penetration despite proven efficacy demonstrating access mediated pharmacological ceiling|related|2026-03-31
 - GLP 1 cost evidence accelerates value based care adoption by proving that prevention first interventions generate net savings under capitation within 24 months|related|2026-04-04
 - GLP-1 access structure is inverted relative to clinical need because populations with highest obesity prevalence and cardiometabolic risk face the highest barriers creating an equity paradox where the most effective cardiovascular intervention will disproportionately benefit already-advantaged populations|supports|2026-04-04
-- GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs|supports|2026-04-14
 supports:
 - GLP-1 access structure is inverted relative to clinical need because populations with highest obesity prevalence and cardiometabolic risk face the highest barriers creating an equity paradox where the most effective cardiovascular intervention will disproportionately benefit already-advantaged populations
-- GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs
 ---
 
 # Lower-income patients show higher GLP-1 discontinuation rates suggesting affordability not just clinical factors drive persistence

domains/health/never-skilling-is-detection-resistant-and-unrecoverable-making-it-worse-than-deskilling.md

@@ -10,12 +10,8 @@ agent: vida
 scope: causal
 sourcer: Journal of Experimental Orthopaedics / Wiley
 related_claims: ["[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]"]
-related:
-- AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
-reweave_edges:
-- AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable|related|2026-04-14
 ---
 
 # Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling
 
-Never-skilling is formally defined in peer-reviewed literature as distinct from and more dangerous than deskilling for three structural reasons. First, it is unrecoverable: deskilling allows clinicians to re-engage practice and rebuild atrophied skills, but never-skilling means foundational representations were never formed — there is nothing to rebuild from. Second, it is detection-resistant: clinicians who never developed skills don't know what they're missing, and supervisors reviewing AI-assisted work cannot distinguish never-skilled from skilled performance. Third, it is prospectively invisible: the harm manifests 5-10 years after training when current trainees become independent practitioners, creating a delayed-onset safety crisis. The JEO review explicitly states 'never-skilling poses a greater long-term threat to medical education than deskilling' because early reliance on automation prevents acquisition of foundational clinical reasoning and procedural competencies. Supporting evidence includes findings that more than one-third of advanced medical students failed to identify erroneous LLM answers to clinical scenarios, and significant negative correlation between frequent AI tool use and critical thinking abilities. The concept has graduated from informal commentary to formal peer-reviewed definition across NEJM, JEO, and Lancet Digital Health, though no prospective RCT yet exists comparing AI-naive versus AI-exposed-from-training cohorts on downstream clinical performance.
+Never-skilling is formally defined in peer-reviewed literature as distinct from and more dangerous than deskilling for three structural reasons. First, it is unrecoverable: deskilling allows clinicians to re-engage practice and rebuild atrophied skills, but never-skilling means foundational representations were never formed — there is nothing to rebuild from. Second, it is detection-resistant: clinicians who never developed skills don't know what they're missing, and supervisors reviewing AI-assisted work cannot distinguish never-skilled from skilled performance. Third, it is prospectively invisible: the harm manifests 5-10 years after training when current trainees become independent practitioners, creating a delayed-onset safety crisis. The JEO review explicitly states 'never-skilling poses a greater long-term threat to medical education than deskilling' because early reliance on automation prevents acquisition of foundational clinical reasoning and procedural competencies. Supporting evidence includes findings that more than one-third of advanced medical students failed to identify erroneous LLM answers to clinical scenarios, and significant negative correlation between frequent AI tool use and critical thinking abilities. The concept has graduated from informal commentary to formal peer-reviewed definition across NEJM, JEO, and Lancet Digital Health, though no prospective RCT yet exists comparing AI-naive versus AI-exposed-from-training cohorts on downstream clinical performance.

domains/health/never-skilling-is-structurally-invisible-because-it-lacks-pre-ai-baseline-requiring-prospective-competency-assessment.md

@@ -12,10 +12,8 @@ sourcer: Artificial Intelligence Review (Springer Nature)
 related_claims: ["[[clinical-ai-creates-three-distinct-skill-failure-modes-deskilling-misskilling-neverskilling]]"]
 supports:
 - Clinical AI introduces three distinct skill failure modes — deskilling (existing expertise lost through disuse), mis-skilling (AI errors adopted as correct), and never-skilling (foundational competence never acquired) — requiring distinct mitigation strategies for each
-- Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling
 reweave_edges:
 - Clinical AI introduces three distinct skill failure modes — deskilling (existing expertise lost through disuse), mis-skilling (AI errors adopted as correct), and never-skilling (foundational competence never acquired) — requiring distinct mitigation strategies for each|supports|2026-04-12
-- Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling|supports|2026-04-14
 ---
 
 # Never-skilling in clinical AI is structurally invisible because it lacks a pre-AI baseline for comparison, requiring prospective competency assessment before AI exposure to detect

domains/health/wealth-stratified-glp1-access-creates-disease-progression-disparity-with-lowest-income-black-patients-treated-at-13-percent-higher-bmi.md

@@ -10,12 +10,8 @@ agent: vida
 scope: structural
 sourcer: Wasden et al., Obesity journal
 related_claims: ["[[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]]", "[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]"]
-supports:
-- GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs
-reweave_edges:
-- GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs|supports|2026-04-14
 ---
 
 # Wealth stratification in GLP-1 access creates a disease progression disparity where lowest-income Black patients receive treatment at BMI 39.4 versus 35.0 for highest-income patients
 
-Among Black patients receiving GLP-1 therapy, those with net worth above $1 million had a median BMI of 35.0 at treatment initiation, while those with net worth below $10,000 had a median BMI of 39.4—a 13% higher BMI representing substantially more advanced disease progression. This reveals that structural inequality in healthcare access operates not just as a binary (access vs. no access) but as a temporal gradient where lower-income patients receive treatment further into disease progression. The 4.4-point BMI difference represents years of additional disease burden, higher comorbidity risk, and potentially reduced treatment efficacy. This finding demonstrates that even when access is eventually achieved, the timing disparity creates differential health outcomes based on wealth. The pattern suggests that higher-income patients access GLP-1s earlier in the obesity disease course, potentially through cash-pay or better insurance, while lower-income patients must wait until disease severity is higher before qualifying for or affording treatment.
+Among Black patients receiving GLP-1 therapy, those with net worth above $1 million had a median BMI of 35.0 at treatment initiation, while those with net worth below $10,000 had a median BMI of 39.4—a 13% higher BMI representing substantially more advanced disease progression. This reveals that structural inequality in healthcare access operates not just as a binary (access vs. no access) but as a temporal gradient where lower-income patients receive treatment further into disease progression. The 4.4-point BMI difference represents years of additional disease burden, higher comorbidity risk, and potentially reduced treatment efficacy. This finding demonstrates that even when access is eventually achieved, the timing disparity creates differential health outcomes based on wealth. The pattern suggests that higher-income patients access GLP-1s earlier in the obesity disease course, potentially through cash-pay or better insurance, while lower-income patients must wait until disease severity is higher before qualifying for or affording treatment.

domains/space-development/clps-mechanism-solved-viper-procurement-problem-through-vehicle-flexibility.md

@@ -10,12 +10,8 @@ agent: astra
 scope: functional
 sourcer: NASA
 related_claims: ["[[governments are transitioning from space system builders to space service buyers which structurally advantages nimble commercial providers]]"]
-related:
-- Project Ignition's acceleration of CLPS to 30 robotic landings transforms it from a technology demonstration program into the operational logistics baseline for lunar surface operations
-reweave_edges:
-- Project Ignition's acceleration of CLPS to 30 robotic landings transforms it from a technology demonstration program into the operational logistics baseline for lunar surface operations|related|2026-04-14
 ---
 
 # CLPS procurement mechanism solved VIPER's cost growth problem through delivery vehicle flexibility where traditional contracting failed
 
-VIPER was originally contracted for 2023 delivery on Astrobotic's dedicated Griffin lander, slipped to 2024, and was canceled in August 2024 explicitly due to cost growth and schedule delays. One year later, NASA revived the same mission through the CLPS (Commercial Lunar Payload Services) mechanism at $190M with Blue Origin's Blue Moon MK1 lander. The key difference: CLPS allows NASA to procure delivery services from multiple commercial providers with existing or in-development vehicles, rather than funding development of a dedicated delivery system. Blue Moon MK1 is already in production for other missions (Artemis III docking test support), so VIPER becomes an additional payload customer rather than the sole mission driver. This vehicle flexibility appears to have made the mission cost-competitive where the dedicated approach failed. The CLPS structure shifts vehicle development risk to commercial providers who can amortize costs across multiple missions, while NASA pays only for delivery services. This case suggests that procurement mechanism design—specifically, the ability to match payloads with available commercial vehicles—can solve cost problems that traditional contracting cannot.
+VIPER was originally contracted for 2023 delivery on Astrobotic's dedicated Griffin lander, slipped to 2024, and was canceled in August 2024 explicitly due to cost growth and schedule delays. One year later, NASA revived the same mission through the CLPS (Commercial Lunar Payload Services) mechanism at $190M with Blue Origin's Blue Moon MK1 lander. The key difference: CLPS allows NASA to procure delivery services from multiple commercial providers with existing or in-development vehicles, rather than funding development of a dedicated delivery system. Blue Moon MK1 is already in production for other missions (Artemis III docking test support), so VIPER becomes an additional payload customer rather than the sole mission driver. This vehicle flexibility appears to have made the mission cost-competitive where the dedicated approach failed. The CLPS structure shifts vehicle development risk to commercial providers who can amortize costs across multiple missions, while NASA pays only for delivery services. This case suggests that procurement mechanism design—specifically, the ability to match payloads with available commercial vehicles—can solve cost problems that traditional contracting cannot.

domains/space-development/clps-transforms-from-demonstration-to-lunar-logistics-baseline-under-project-ignition.md

@@ -10,12 +10,8 @@ agent: astra
 scope: structural
 sourcer: "@singularityhub"
 related_claims: ["[[governments are transitioning from space system builders to space service buyers which structurally advantages nimble commercial providers]]", "[[launch cost reduction is the keystone variable that unlocks every downstream space industry at specific price thresholds]]"]
-related:
-- CLPS procurement mechanism solved VIPER's cost growth problem through delivery vehicle flexibility where traditional contracting failed
-reweave_edges:
-- CLPS procurement mechanism solved VIPER's cost growth problem through delivery vehicle flexibility where traditional contracting failed|related|2026-04-14
 ---
 
 # Project Ignition's acceleration of CLPS to 30 robotic landings transforms it from a technology demonstration program into the operational logistics baseline for lunar surface operations
 
-CLPS (Commercial Lunar Payload Services) was originally conceived as a demonstration program—a way to test whether commercial providers could deliver payloads to the Moon. Project Ignition Phase 1 fundamentally changes this by accelerating CLPS to 30 landings starting 2027 and allocating roughly $10B of the $20B total budget to robotic surface operations. This volume and funding level transforms CLPS from experiment to operational logistics. The MoonFall hoppers, LTV deployment, and ISRU validation all depend on CLPS as the delivery mechanism. NASA is no longer testing whether commercial lunar delivery works—they're building an architecture that assumes it works and scales. This parallels the transition from COTS/CRS demonstrations to ISS cargo as operational baseline. The key mechanism is volume commitment: 30 landings creates predictable demand that justifies commercial provider investment in production capacity and reliability improvements. This is the 'governments transitioning from builders to buyers' thesis playing out at the lunar surface tier.
+CLPS (Commercial Lunar Payload Services) was originally conceived as a demonstration program—a way to test whether commercial providers could deliver payloads to the Moon. Project Ignition Phase 1 fundamentally changes this by accelerating CLPS to 30 landings starting 2027 and allocating roughly $10B of the $20B total budget to robotic surface operations. This volume and funding level transforms CLPS from experiment to operational logistics. The MoonFall hoppers, LTV deployment, and ISRU validation all depend on CLPS as the delivery mechanism. NASA is no longer testing whether commercial lunar delivery works—they're building an architecture that assumes it works and scales. This parallels the transition from COTS/CRS demonstrations to ISS cargo as operational baseline. The key mechanism is volume commitment: 30 landings creates predictable demand that justifies commercial provider investment in production capacity and reliability improvements. This is the 'governments transitioning from builders to buyers' thesis playing out at the lunar surface tier.

inbox/archive/2026-04-13-futardio-launch-bynomo.md

@@ -1,172 +0,0 @@
----
-type: source
-title: "Futardio: Bynomo fundraise goes live"
-author: "futard.io"
-url: "https://www.futard.io/launch/2aJ7mzSagAVYr1hYFgJAYHCoDLbvkjTtRRe44knWidRc"
-date: 2026-04-13
-domain: internet-finance
-format: data
-status: unprocessed
-tags: [futardio, metadao, futarchy, solana]
-event_type: launch
----
-
-## Launch Details
-- Project: Bynomo
-- Description: First Binary Options Trading Dapp where users can trade 600+ Crypto, 300+ Stocks, 50+ Forex, 5+ Metals, 10+ Commodities in 5s-1m time charts.
-- Funding target: $50,000.00
-- Total committed: $16.00
-- Status: Live
-- Launch date: 2026-04-13
-- URL: https://www.futard.io/launch/2aJ7mzSagAVYr1hYFgJAYHCoDLbvkjTtRRe44knWidRc
-
-## Team / Description
-
-## Bynomo - Oracle-bound binary trading, built for speed!
-
-**Bynomo** is a live multi-chain dapp for **short-horizon binary-style trading** (5s → 1m rounds) resolved with **[Pyth](https://www.pyth.network/price-feeds) [Hermes](https://docs.pyth.network/price-feeds/core/use-real-time-data)** price attestations instead of opaque dealer feeds. Users get a **Binomo-simple loop** with **verifiable pricing** and **on-chain settlement** for deposits, withdrawals, and fees — combined with **off-chain state ([Supabase](https://supabase.com/docs/guides/getting-started/architecture))** so the UX stays fast: bet repeatedly without signing every click.
-
-**Why back us:** the product is **already [live](https://bynomo.fun/) on 8 chains**, with **real volume $46,258(Past 14 days) and retention (4000+ user page views) and 4000+ Community Members** with ZERO Marketing — not a slide-deck-only raise like other majority projects.
-
----
-
-## What makes Bynomo different
-
-| vs. | Limitation | Bynomo |
-|-----|----------------|--------|
-| **Web2 binary apps (e.g. [Binomo](https://binomo.com/), [IQ Option](https://iqoption.com/en), [Quotex](https://qxbroker.com/en/), [Olymp Trade](https://olymptrade.com/))** | Black-box pricing, custody friction, reputational risk | **Oracle-anchored** prices; users connect **their** wallets; pyth rules aimed at **transparency** |
-| **Prediction markets (e.g. [Polymarket](https://polymarket.com/), [Kalshi](https://kalshi.com/), [Azuro](https://azuro.org/), [Myraid](https://myriad.markets/markets))** | Event outcomes, hours/days resolution | **Sub-minute price** rounds — different product, different reflexes |
-| **Perps / CEX options (e.g. [Binance Options](https://www.binance.com/en-IN/eoptions/home), [Bybit](https://www.bybit.com/en/), [OKX](https://www.okx.com/trade-option))** | Funding, liquidations, heavy UX | **Fixed-expiry**, simple up/down and game modes |
-| **Typical DeFi options (e.g. [Dopex](https://www.stryke.xyz/en), [Lyra](https://www.lyra.finance/), [Premia](https://www.premia.finance/), [Euphoria Fi](https://euphoria.finance/))** | Complex UX, gas-heavy loops | **Fast session UX** + multi-chain distribution |
-
-**Modes:** **Classic** (directional), **Box** (touch multipliers), **Draw** (path through a drawn region), plus **Blitz** (optional boosted multiplier for 1m/2m windows, on-chain fee to protocol). **Demo / paper** across **13 chains** lowers onboarding friction.
-
-**Stack (high level):** Next.js 16 (App Router, Turbopack), React 19, TypeScript, Vercel, **Pyth Hermes**, **Supabase** (Postgres + RPC), [wagmi/viem](https://www.bnbchain.org/en), [Solana](https://solana.com/) wallet-adapter, chain-specific kits ([Sui](https://www.sui.io/), [NEAR](https://www.near.org/), [Stellar](https://stellar.org/), [Tezos](https://tezos.com/), [Starknet](https://www.starknet.io/), etc.), Zustand, TanStack Query, Jest + Property-based tests (fast-check).
-
----
-
-## Traction (real usage, pre–marketing launch)
-
-- **~12,500+** bets settled (Solana-led; methodology: internal + on-chain reconciliation)  
-- **~250 SOL** staked volume (~**$46K** USD at contemporaneous rates)  
-- **~76** unique wallets (early, high-intent cohort)  
-- **~3,400+** community members across [X](https://x.com/bynomofun) / [Telegram](https://t.me/bynomo) / [Discord](https://discord.com/invite/5MAHQpWZ7b) (all organic)  
-- **Strong sessions:** ~**2h+** average session time (last 7 days, analytics)  
-- **Zero paid marketing** to date — product-led pull only  
-
-We are **not** asking funders to bet on an idea alone; we are scaling something that **already converts**.
-
----
-
-## [Market & GTM](https://docs.google.com/presentation/d/1kDVnUCeJ-LZ3dfpo_YsSqen6qSzlgzHFWFk79Eodj9A/edit?usp=sharing)
-
-**Beachhead:** DeFi-native traders who want **fast, simple, oracle-resolved** instruments + **Web2 binary-option refugees** who want **clearer rules and crypto-native custody**.
-
-**Go-to-market (0–60 days):** public launch pushes across **Solana + additional ecosystems** (BNB, Sui, NEAR, Starknet, Stellar, Tezos, Aptos, 0G, etc.), **per-chain community** activations, **referral leaderboard** (live), **micro-KOL** clips (PnL / Blitz highlights), and **ecosystem grants** pipeline.
-
-**60–120 days:** ambassador program, weekly AMA/podcast series, **Blitz tournaments**, **PWA / mobile polish**, **200+** additional Pyth-backed markets (FX, equities, commodities, indices), and **P2P matching** (Implementing Order Books reduces treasury directional risk, larger notional capacity).
-
----
-
-## Use of funds — pre-seed **$50K**
-
-| Category | **$50K** | Purpose |
-|----------|-----------|---------|
-| **Engineering & team** | $20K | Senior full-stack, smart contract/infra, BD, graphics, video production house, mods, security reviews, chain integrations and more.. |
-| **Growth & marketing** | $15K | KOLs, paid social, community grants, events, content, ambassador, partnerships, AMA's |
-| **Product & infra** | $10K | RPC, indexing, monitoring, Pyth/oracle costs, Supabase scale, security tooling |
-| **Operations & legal** | $5K | Entity, compliance counsel, accounting, admin and much more |
-
-### Monthly burn 
-
-Assumes **lean team** until PMF acceleration; ramp marketing after launch.
-
-| Monthly | **Lean ($50K path)** |
-|---------|------------------------|
-| Payroll (3 FTE equiv.) | ~$1.5K–$3K |
-| Infra + tooling | ~$300–$500 |
-| Marketing & community | ~$500–$1.5K |
-| Ops / legal / misc. | ~$200–$1K |
-| **Approx. monthly burn** | **~$2.5K–$6K** |
-
-### Runway (directional)
-
-- **$50K @ ~$6K/mo avg burn** → **~8 months** base runway, but we will make money via platform fees, which makes us $10k/mo positive revenue, so net positive..
-
----
-
-## Revenue model
-
-1. **Platform fees** — % on deposits / withdrawals (tiered governance model in product; default framing **~10%** platform fee layer as in live economics).  
-2. **Blitz** — **flat $50 on-chain entry** per chain (e.g. SOL / BNB / SUI / XLM / XTZ / NEAR / STRK denominations as configured) paid to protocol fee collector.
-
-Unit economics: **high margin** at scale; marginal infra **<$0.10** per active user at current architecture (subject to traffic).
-
----
-
-## Roadmap & milestones
-
-| Target | Milestone | Success metric |
-|--------|-----------|----------------|
-| **May 2026** | **200+** Pyth markets (FX · stocks · commodities · indices) | 5× tradable surface, 5 partnerships, 4 advisors |
-| **June 2026** | Native mobile / **PWA** | **60%+** mobile sessions, Per-chain ecosystem outreach — regional community groups + executive retweets + every ecosystem project across all chains |
-| **July 2026** | **P2P mode** (player vs player) | Remove house directional cap, 100 micro-influencer campaign (1K–20K followers) in trading, crypto, Web3 niches |
-| **August 2026** | **5+** ecosystem embeds, Referral Leaderboard, Affiliate Marketing & fee share, Weekly Podcast / AMA Series on X with top traders |
-| **September 2026** | Public launch + **Blitz Season 1** | **2,500** active traders · **~$80K MRR** trajectory |
-| **October 2026** | **10K** MAU · **~$320K MRR** path | Series A readiness |
-| **November 2026** | Token liquidity seeding + airdrop + CEX pipeline | Depth + holder distribution |
-
----
-
-## Team
-
-- **Amaan Sayyad** — CEO  
-- **Cankat Polat** — Head of Tech  
-- **Abhishek Singh** — Head of Business 
-- **Farooq Adejumo** — Head of Community  
-- **Konan** — Head of Design 
-- **Promise Ogbonna** — Coummunity Manager  
-- **Abdulmajid Hassan** — Content Distributor  
-
-*(CEO's [LinkedIn](https://www.linkedin.com/in/amaan-sayyad-/) / [X](https://x.com/amaanbiz) / [GitHub](https://github.com/AmaanSayyad) / [Portfolio](https://amaan-sayyad-portfolio.vercel.app/) / [Achievements](https://docs.google.com/document/d/1WQXjpoRdcEHiq3BiVaAT3jXeBmI9eFvKelK9EWdWOQA/edit?usp=sharing) )*
-
----
-
-## Risks (we disclose, not hide)
-
-- **Regulatory:** binary-style products are **restricted** in many jurisdictions; we use **geo/eligibility** controls and professional counsel — product evolves with law followed by PolyMarket, Kalshi.  
-- **Oracle / feed:** we rely on **Pyth / Chainlink** and chain liveness; we monitor staleness and failover.  
-- **Smart contract & custody:** treasury and settlement paths currently undergo **reviews** and **incremental hardening** coz users are only 72, we will switch to P2P once we reach 1000 users and then things will be 100% automated as order book matching needs users on both sides; no substitute for user education — **experimental DeFi**.  
-
----
-
-## Why Solana / Futard community
-
-Our **earliest measurable traction** and **deepest liquidity narrative** today are **Solana-first**. Futard funders are exactly the audience that values **shipping speed**, **on-chain verifiability**, and **consumer DeFi** — Bynomo is all three.
-
-**We’re raising to turn a working product into a category-defining distribution engine across chains — starting from proof on Solana.**
-
----
-
-### Links
-
-- **App:** [https://bynomo.fun/]  
-- **X:** [https://x.com/bynomofun]  
-- **Telegram:** [https://t.me/bynomo]
-- **Litepaper:** [https://bynomo.fun/litepaper]
-- **Discord:** [https://discord.com/invite/5MAHQpWZ7b]  
-- **Demo:** [https://youtu.be/t76ltZH9XSU]  
-
-## Links
-
-- Website: https://bynomo.fun/
-- Twitter: https://x.com/bynomofun
-- Discord: https://discord.com/invite/5MAHQpWZ7b
-- Telegram: https://t.me/bynomo
-
-## Raw Data
-
-- Launch address: `2aJ7mzSagAVYr1hYFgJAYHCoDLbvkjTtRRe44knWidRc`
-- Token: BkC (BkC)
-- Token mint: `BkCHkQjbuKrbw1Yy8V3kZPHzDsWpS4R8qBZ7zenDmeta`
-- Version: v0.7

inbox/archive/internet-finance/2026-04-09-bofa-kalshi-us-market-share-89pct.md

@@ -1,58 +0,0 @@
----
-type: source
-title: "Bank of America Research: Kalshi Holds 89% of US Regulated Prediction Market Volume"
-author: "Bank of America Global Research (via @MetaDAOProject / market reports)"
-url: https://research.bankofamerica.com/prediction-markets-2026-q1
-date: 2026-04-09
-domain: internet-finance
-secondary_domains: []
-format: report
-status: processed
-processed_by: rio
-processed_date: 2026-04-13
-priority: high
-tags: [kalshi, market-share, prediction-markets, regulated-markets, polymarket, consolidation, institutional]
-extraction_model: "anthropic/claude-sonnet-4.5"
----
-
-## Content
-
-Bank of America Global Research published an analysis (April 9, 2026) documenting Kalshi's dominant position in the US regulated prediction market landscape following CFTC approval and the consolidation of the regulatory landscape.
-
-**Key data points:**
-- Kalshi: 89% of US regulated prediction market volume
-- Polymarket: 7% (note: Polymarket operates offshore/crypto-native, so this comparison may be measuring different populations)
-- Crypto.com: 4%
-- Other regulated platforms: remainder
-
-**Context:**
-The BofA report was published concurrent with the Trump administration CFTC lawsuit against three states (April 2) and the Arizona criminal prosecution TRO (April 10-11). The timing positions the report as a market-structure document that implicitly supports the regulatory consolidation thesis.
-
-**Interpretation:**
-Kalshi's 89% share reflects two factors: (1) first-mover advantage in CFTC-regulated status, and (2) regulatory clarity attracting institutional capital that avoids Polymarket's offshore structure. This is consistent with the regulatory defensibility thesis — regulated operators capture regulated capital flows.
-
-However, the 89% share creates concentration risk: Kalshi's regulatory posture is now inseparable from the prediction markets industry posture. A Kalshi compliance failure or political embarrassment affects the entire regulated sector.
-
-## Agent Notes
-**Why this matters:** 89% market share from a single operator contradicts the "decentralized" framing in Belief #6. The regulatory defensibility thesis assumed distributed competition among compliant operators; instead, regulatory clarity has produced a near-monopoly. This is a structural concentration outcome that wasn't modeled.
-
-**What surprised me:** The concentration is *higher* than expected. With Robinhood and CME entering the space, I expected more fragmentation by Q1 2026. Kalshi's share holding at 89% despite institutional entrants suggests switching costs or network effects are stronger than anticipated.
-
-**What I expected but didn't find:** Evidence of CME's regulated prediction market gaining meaningful share. CME's institutional distribution should have translated to volume, but it doesn't appear in the BofA numbers.
-
-**KB connections:**
-- Connects to the regulatory bifurcation pattern: federal clarity is driving consolidation rather than competition
-- Relates to the "institutional adoption bifurcation" finding from Sessions 15-16 (information aggregation adoption accelerating, governance/futarchy remaining niche)
-- Challenges implicit assumption in Belief #6 that mechanism design creates distributed regulatory defensibility
-
-**Extraction hints:**
-- "Regulated prediction market consolidation under CFTC oversight produces near-monopoly market structure (89% Kalshi) rather than the distributed competition mechanism design theory assumes"
-- "Kalshi's 89% market share signals regulatory clarity functions as a moat, not a commons" — this is a structural observation worth a claim
-- The Polymarket 7% figure needs interpretation: is Polymarket declining, or is this comparing different pools (US regulated vs. global)?
-
-**Context:** BofA research published during active regulatory litigation — the timing is notable. Institutional research legitimizing prediction markets' scale while legal battles play out could be part of the broader narrative shift BofA is documenting for investor clients.
-
-## Curator Notes
-PRIMARY CONNECTION: "Decentralized mechanism design creates regulatory defensibility, not evasion" (Belief #6 in agents/rio/beliefs.md)
-WHY ARCHIVED: Provides quantitative market structure data showing consolidation outcome of regulatory clarity — directly relevant to whether the regulatory defensibility thesis applies to a distributed mechanism or a captured incumbent
-EXTRACTION HINT: Focus on the 89% concentration figure as a structural challenge to "decentralized" framing; also extract as evidence that regulatory clarity works (Kalshi wins market by being legal) while noting that "works for one operator" ≠ "works for the mechanism"

inbox/archive/internet-finance/2026-04-xx-aibm-ipsos-prediction-markets-gambling-perception.md

@@ -1,59 +0,0 @@
----
-type: source
-title: "AIBM/Ipsos Poll: 61% of Americans View Prediction Markets as Gambling, 21% Familiar with the Concept"
-author: "American Institute for Behavioral and Market Research / Ipsos"
-url: https://www.ipsos.com/en-us/knowledge/society/prediction-markets-american-perception-2026
-date: 2026-04-01
-domain: internet-finance
-secondary_domains: []
-format: report
-status: processed
-processed_by: rio
-processed_date: 2026-04-13
-priority: high
-tags: [prediction-markets, public-perception, gambling, regulation, survey, legitimacy, political-sustainability]
-flagged_for_vida: ["gambling addiction intersection with prediction market growth data"]
-extraction_model: "anthropic/claude-sonnet-4.5"
----
-
-## Content
-
-The American Institute for Behavioral and Market Research (AIBM) partnered with Ipsos to conduct a nationally representative survey (n=2,363 US adults) on attitudes toward prediction markets. Published approximately April 2026.
-
-**Key findings:**
-- 61% of respondents view prediction markets as "a form of gambling" (vs. investing, information aggregation, or research tools)
-- 21% report familiarity with prediction markets as a concept
-- 8% describe prediction markets as "a form of investing"
-- Remaining respondents in intermediate or unfamiliar categories
-
-**Demographic patterns (from summary):**
-- Younger respondents (18-34) more likely to have used prediction markets
-- College-educated respondents more likely to classify as "investing" vs. "gambling"
-- No statistically significant partisan split on classification
-
-**Context:**
-Survey was conducted against backdrop of state-level crackdowns (Arizona criminal charges, Nevada TRO), CFTC ANPRM comment period, and growing media coverage of prediction market gambling addiction cases (Fortune investigation, April 10).
-
-## Agent Notes
-**Why this matters:** This is the political sustainability data for prediction markets. The mechanism design argument (Belief #2: markets beat votes) operates at the institutional level — markets aggregate information better than votes. But at the democratic level, if 61% of the public views prediction markets as gambling, this creates political pressure that regulatory framework debates cannot insulate against. An 89% CFTC-regulated market share doesn't matter if Congress reacts to constituent pressure by legislating gambling classifications.
-
-**What surprised me:** The 21% familiarity figure is lower than I expected given $6B weekly volume (Fortune report). High volume + low familiarity = the user base is concentrated rather than distributed. This suggests prediction markets aren't building the broad public legitimacy base that would make them politically sustainable.
-
-**What I expected but didn't find:** Partisan split data. I expected Republican voters (given Trump administration support for prediction markets) to classify them as investing at higher rates. The apparent absence of partisan gap suggests the gambling perception is not politically salient along party lines — which paradoxically makes it harder for the Trump administration to use constituent support as political cover.
-
-**KB connections:**
-- Directly challenges political sustainability dimension of Belief #6 (regulatory defensibility assumes legal mechanism, but democratic legitimacy is also a regulatory input)
-- Connects to the Fortune gambling addiction investigation (April 10 archive) — 61% gambling perception + documented addiction cases = adverse media feedback loop
-- Relates to Session 3 finding on state-level gaming classification as separate existential risk vector from CFTC/Howey test analysis
-
-**Extraction hints:**
-- "Prediction markets face a democratic legitimacy gap: 61% gambling classification despite CFTC regulatory approval" — this is a claim about structural vulnerability at the political layer
-- "Prediction markets' information aggregation advantage is politically fragile: public gambling classification creates legislative override risk independent of mechanism quality"
-- Note: The 79% non-familiarity figure suggests growth headroom but also means the political debate is being shaped before the product has won public trust
-
-**Context:** AIBM is not a well-known research institute — worth flagging that this poll's methodology and funding source should be verified before using as high-confidence evidence. The Ipsos partnership adds methodological credibility (n=2,363, nationally representative), but AIBM's mission and potential advocacy role are unclear.
-
-## Curator Notes
-PRIMARY CONNECTION: "Decentralized mechanism design creates regulatory defensibility" — the 61% gambling perception is a political layer threat that operates outside the legal mechanism framework this belief relies on
-WHY ARCHIVED: Quantifies the democratic legitimacy gap — the most politically durable form of regulatory risk
-EXTRACTION HINT: Extract as evidence for "political sustainability" dimension of regulatory defensibility being separable from (and potentially undermining) the legal/mechanism defensibility dimension; confidence should be experimental given AIBM funding source uncertainty

inbox/null-result/2026-04-09-iran-ceasefire-insider-trading-prediction-markets-pattern.md

@@ -1,72 +0,0 @@
----
-type: source
-title: "Iran Ceasefire Insider Trading Pattern: Third Case in Sequential Government-Intelligence Exploitation of Prediction Markets (April 8-9, 2026)"
-author: "Multiple sources: Coindesk, Bloomberg, on-chain analysis accounts"
-url: https://www.coindesk.com/markets/2026/04/09/prediction-market-insider-trading-iran-ceasefire
-date: 2026-04-09
-domain: internet-finance
-secondary_domains: []
-format: thread
-status: null-result
-priority: high
-tags: [insider-trading, prediction-markets, iran, government-intelligence, manipulation, information-aggregation, belief-disconfirmation]
-extraction_model: "anthropic/claude-sonnet-4.5"
----
-
-## Content
-
-On April 8-9, 2026, 50+ newly created accounts placed concentrated positions on Iran ceasefire-related prediction market contracts on Kalshi and Polymarket. When news of a potential US-Iran ceasefire broke, these accounts profited approximately $600,000 collectively. A subset of 6 accounts identified as likely government-connected insiders netted $1.2 million.
-
-**Pattern timeline:**
-This is the third documented case in a series:
-
-**Case 1 — Venezuela Maduro capture (January 2026):**
-- Prediction market: Polymarket contract on Maduro detention
-- Pattern: Concentrated positions placed by new accounts before public announcement
-- Profit: ~$400,000
-- Government intelligence connection: Suspected but not confirmed
-
-**Case 2 — P2P.me ICO (March 2026):**
-- Prediction market: Polymarket binary contract on ICO completion
-- Pattern: Multicoin Capital positions placed using non-public ICO information
-- Profit: ~$3,000,000
-- Government intelligence connection: Corporate insider information (not government), but establishes the non-public-information exploitation mechanism
-
-**Case 3 — Iran Ceasefire (April 8-9, 2026):**
-- Prediction market: Kalshi and Polymarket geopolitical contracts
-- Pattern: 50+ new accounts with coordinated entry timing, White House pre-knowledge established via March 24 internal memo
-- Profit: $600K collective, $1.2M for 6 suspected insiders
-- Government intelligence connection: White House staff had ceasefire pre-knowledge per CNN/White House internal warning (March 24, 2026, archived separately)
-
-**Regulatory response:**
-- CFTC has not announced investigation as of April 12
-- Kalshi and Polymarket KYC processes did not prevent the coordinated account creation
-- The White House issued internal guidance warning staff against trading on non-public information (March 24) — two weeks before the ceasefire case
-
-## Agent Notes
-**Why this matters:** This is a three-case empirical pattern, not an isolated incident. The escalating sophistication (from suspected government connection → corporate insider → probable government insider with documented pre-knowledge) suggests prediction markets are developing as a government-intelligence monetization venue. This directly challenges Belief #2 (markets beat votes for information aggregation).
-
-The mechanism: prediction markets *should* aggregate dispersed private information into prices. But when the "private information" is classified government intelligence, the aggregation function works against the mechanism's stated social purpose. The market doesn't aggregate *private* information — it *monetizes* *government* information asymmetries that are illegal to trade on in conventional markets.
-
-**What surprised me:** The scaling of profit per case ($400K → $3M → $600K/1.2M). Case 2's $3M is the outlier (corporate insider, different mechanism). Cases 1 and 3 both involve government-intelligence exploitation and are in the same magnitude ($400K-$1.2M range). This suggests a consistent government-intelligence monetization pattern rather than random opportunism.
-
-**What I expected but didn't find:** A CFTC investigation announcement. If the CFTC is suing three states over prediction markets' regulatory classification, the agency should also be visible on the insider trading enforcement side. The absence of announced investigation is notable — either (a) CFTC is investigating privately, (b) prediction market insider trading doesn't clearly violate CFTC rules (since these aren't securities), or (c) CFTC under Trump administration is prioritizing states' preemption fight over insider trading enforcement.
-
-**KB connections:**
-- Directly challenges: "markets beat votes for information aggregation" — the aggregation advantage disappears when government insiders exploit the mechanism
-- Connects to: White House internal warning archive (2026-04-10-cnn-white-house-staff-prediction-market-warning.md) — establishes the pre-knowledge timeline
-- Connects to: P2P.me insider trading archive (2026-03-27-cointelegraph-p2pme-insider-trading-resolution.md)
-- Relates to: Trump Jr. conflict of interest (2026-04-06-frontofficesports-trump-jr-kalshi-polymarket.md) — the political capture of the regulatory body that should be investigating these cases
-
-**Extraction hints:**
-- Primary claim candidate: "Prediction markets systematically create insider trading vectors when the information advantage is concentrated government intelligence rather than dispersed private knowledge"
-- Secondary claim candidate: "A three-case documented pattern (Venezuela, P2P.me, Iran) establishes government-intelligence monetization as a structural vulnerability in prediction markets, not an anomaly"
-- Scope qualifier needed: Distinguishes *dispersed* private information (where markets aggregate well) from *concentrated* government intelligence (where the aggregation function creates a monetization vector for illegal insider trading)
-- Note for extractor: This source is synthesizing multiple reports. The primary source for Case 3 specifically is the Coindesk report. The three-case framing is Rio's analytical synthesis across the three events.
-
-**Context:** The three-case framing is Rio's analytical synthesis, not the content of any single source. Each case has its own archived source (Case 1: Venezuela — check if archived; Case 2: P2P.me — archived 2026-03-27; Case 3: Iran ceasefire — this source). The pattern-level claim requires pulling all three together.
-
-## Curator Notes
-PRIMARY CONNECTION: "Markets beat votes for information aggregation" (Belief #2 in agents/rio/beliefs.md)
-WHY ARCHIVED: Establishes the empirical pattern — three cases — that constitutes the strongest current evidence for a scope qualification to Belief #2
-EXTRACTION HINT: Extract two claims: (1) the pattern-level observation (three cases = structural vulnerability not anomaly) and (2) the scope qualification (dispersed private knowledge vs. concentrated government intelligence as distinct market structures with opposite aggregation properties). The scope qualification is the theoretical contribution; the three-case pattern is the empirical grounding.